{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:21:24Z","timestamp":1792783284614,"version":"4.5.0"},"reference-count":316,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"A.H. Couch Trust and National Heart Foundation of New Zealand","award":["#2003"],"award-info":[{"award-number":["#2003"]}],"id":[{"id":"https:\/\/ror.org\/02xwkbq98","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001518","name":"Maurice and Phyllis Paykel Trust","doi-asserted-by":"publisher","award":["#251112"],"award-info":[{"award-number":["#251112"]}],"id":[{"id":"10.13039\/501100001518","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The antipsychotic drug clozapine is associated with one of the broadest spectra of cardiac adverse effects. Many of these are of unknown aetiology, hindering clinicians\u2019 ability to prevent, diagnose, and treat them. Risk factors for clozapine-associated cardiotoxicities include concomitant valproic acid therapy and comorbidities associated with the dysregulation of systemic metabolism, such as obesity and diabetes. Therefore, this review aims to summarise existing evidence for the adverse effects of these drugs on cellular and systemic energetics. Both drugs are strongly associated with mitochondrial dysfunction and oxidative stress, but in different tissues. Clozapine may be bioactivated within cardiomyocytes and their mitochondria, producing reactive species that damage these organelles, thus impairing oxidative phosphorylation. Valproate may have similar effects in hepatocytes but doesn\u2019t appear to be bioactivated in all cell types, though it reportedly has modest inhibitory effects on fatty acid oxidation. Both drugs affect substrate supply, altering serum lipid, carbohydrate, and ketone levels. In concert, these medications are likely to impair cardiac metabolic flexibility and energetics. Considering the absolute dependence of cardiomyocyte function on continuous energy supply, the dysregulation of cardiomyocyte energetics is likely to have a significant role in the development of clozapine-associated cardiotoxicities. However, limited investigation has been made of the effects of these drugs in cardiomyocytes specifically. Rectifying this could inform improved prevention, detection, and management of cardiotoxicities to facilitate the development of clinical strategies to enable the safer use of these medicines.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>\n                  <jats:p>Overview of the potential effects of clozapine and valproic acid on cardiomyocyte energetics. Highlighted regions are those where clozapine (orange) or valproic acid (purple) have been shown to have some effect, with colour-coded arrows to indicate the direction of the effect. Partially shaded regions indicate those areas where contradictory effects have been reported in different experimental models. Key enzymes, indicated in brackets, include glutamine synthetase (GS), glutamate synthase (GLS), glutamate dehydrogenase (GDH), glutamate-pyruvate transaminase (GPT), lactate dehydrogenase (LDH), pyruvate dehydrogenase (PDH), and fatty acyl-CoA synthetase (FACS).<\/jats:p>","DOI":"10.1007\/s12012-026-10204-w","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:03:28Z","timestamp":1792141408000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Role of Sodium Valproate in Clozapine-Associated Cardiotoxicities: The Importance of Cellular and Systemic Energetics"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7915-5542","authenticated-orcid":false,"given":"Amanda","family":"Groenewald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia S.","family":"Power","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn E.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm D.","family":"Tingle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Louise","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"10204_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1192\/bjp.2021.61","volume":"220","author":"D Siskind","year":"2022","unstructured":"Siskind, D., Orr, S., Sinha, S., Yu, O., Brijball, B., Warren, N., MacCabe, J. H., Smart, S. E., & Kisely, S. (2022). Rates of treatment-resistant schizophrenia from first-episode cohorts: Systematic review and meta-analysis. The British Journal of Psychiatry,220, 115\u2013120. https:\/\/doi.org\/10.1192\/bjp.2021.61","journal-title":"The British Journal of Psychiatry"},{"key":"10204_CR2","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","volume":"174","author":"OD Howes","year":"2017","unstructured":"Howes, O. D., McCutcheon, R., Agid, O., de Bartolomeis, A., van Beveren, N. J. M., Birnbaum, M. L., Bloomfield, M. A. P., Bressan, R. A., Buchanan, R. W., Carpenter, W. T., Castle, D. J., Citrome, L., Daskalakis, Z. J., Davidson, M., Drake, R. J., Dursun, S., Ebdrup, B. H., Elkis, H., Falkai, P., \u2026 Correll, C. U. (2017). Treatment-resistant schizophrenia: Treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology. American Journal of Psychiatry,174, 216\u2013229. https:\/\/doi.org\/10.1176\/appi.ajp.2016.16050503","journal-title":"American Journal of Psychiatry"},{"key":"10204_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pnpbp.2015.08.010","volume":"65","author":"F Iasevoli","year":"2016","unstructured":"Iasevoli, F., Giordano, S., Balletta, R., Latte, G., Formato, M. V., Prinzivalli, E., De Berardis, D., Tomasetti, C., & de Bartolomeis, A. (2016). Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones. Progress in Neuro-Psychopharmacology & Biological Psychiatry,65, 34\u201348. https:\/\/doi.org\/10.1016\/j.pnpbp.2015.08.010","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10204_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41537-021-00192-x","volume":"8","author":"CU Correll","year":"2022","unstructured":"Correll, C. U., Martin, A., Patel, C., Benson, C., Goulding, R., Kern-Sliwa, J., Joshi, K., Schiller, E., & Kim, E. (2022). Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics. Schizophrenia,8, Article Article 5. https:\/\/doi.org\/10.1038\/s41537-021-00192-x","journal-title":"Schizophrenia"},{"key":"10204_CR5","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1177\/0706743717718167","volume":"62","author":"D Siskind","year":"2017","unstructured":"Siskind, D., Siskind, V., & Kisely, S. (2017). Clozapine response rates among people with treatment-resistant schizophrenia: Data from a systematic review and meta-analysis. The Canadian Journal of Psychiatry,62, 772\u2013777. https:\/\/doi.org\/10.1177\/0706743717718167","journal-title":"The Canadian Journal of Psychiatry"},{"key":"10204_CR6","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1001\/jamapsychiatry.2019.1702","volume":"76","author":"T Masuda","year":"2019","unstructured":"Masuda, T., Misawa, F., Takase, M., Kane, J. M., & Correll, C. U. (2019). Association with hospitalization and all-cause discontinuation among patients with schizophrenia on clozapine vs other oral second-generation antipsychotics: A systematic review and meta-analysis of cohort studies. JAMA Psychiatry,76, 1052\u20131062. https:\/\/doi.org\/10.1001\/jamapsychiatry.2019.1702","journal-title":"JAMA Psychiatry"},{"key":"10204_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.schres.2004.05.015","volume":"73","author":"J Hennen","year":"2005","unstructured":"Hennen, J., & Baldessarini, R. J. (2005). Suicidal risk during treatment with clozapine: A meta-analysis. Schizophrenia Research,73, 139\u2013145. https:\/\/doi.org\/10.1016\/j.schres.2004.05.015","journal-title":"Schizophrenia Research"},{"key":"10204_CR8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1001\/archpsyc.60.1.82","volume":"60","author":"Meltzer, H.Y., Alphs, L., Green, A.I., Altamura, A.C., Anand, R., Bertoldi, A., Bourgeois, M., Chouinard, G., Islam, M.Z., Kane, J., Krishnan, R., Lindenmayer, J.P., Potkin, S. and InterSePT Study Group","year":"2003","unstructured":"Meltzer, H.Y., Alphs, L., Green, A.I., Altamura, A.C., Anand, R., Bertoldi, A., Bourgeois, M., Chouinard, G., Islam, M.Z., Kane, J., Krishnan, R., Lindenmayer, J.P., Potkin, S. and InterSePT Study Group. (2003). Clozapine Treatment for Suicidality in Schizophrenia: International Suicide Prevention Trial (InterSePT). Archives of General Psychiatry,60, 82\u201391. https:\/\/doi.org\/10.1001\/archpsyc.60.1.82","journal-title":"Archives of General Psychiatry"},{"key":"10204_CR9","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/S0006-3223(03)00178-1","volume":"54","author":"SG Potkin","year":"2003","unstructured":"Potkin, S. G., Alphs, L., Hsu, C., Ranga Rama Krishnan, K., Anand, R., Young, F. K., Meltzer, H., & Green, A. (2003). Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective two-year trial. Biological Psychiatry,54, 444\u2013452. https:\/\/doi.org\/10.1016\/S0006-3223(03)00178-1","journal-title":"Biological Psychiatry"},{"key":"10204_CR10","unstructured":"WHO Expert Committee. (2013). The selection and use of essential medicines, in WHO Technical Report Series"},{"key":"10204_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1176\/appi.books.9780890424841.Schizophrenia03","volume-title":"The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia","author":"American Psychiatric Association","year":"2020","unstructured":"American Psychiatric Association. (2020). Guideline statements and implementation. The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia (pp. 7\u2013138). American Psychiatric Publishing."},{"key":"10204_CR12","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1177\/0004867416641195","volume":"50","author":"C Galletly","year":"2016","unstructured":"Galletly, C., Castle, D., Dark, F., Humberstone, V., Jablensky, A., Killackey, E., Kulkarni, J., McGorry, P., Nielssen, O., & Tran, N. (2016). Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Australian and New Zealand Journal of Psychiatry,50, 410\u2013472. https:\/\/doi.org\/10.1177\/0004867416641195","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"key":"10204_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.psychres.2017.01.064","volume":"250","author":"B Yoshimura","year":"2017","unstructured":"Yoshimura, B., Yada, Y., So, R., Takaki, M., & Yamada, N. (2017). The critical treatment window of clozapine in treatment-resistant schizophrenia: Secondary analysis of an observational study. Psychiatry Research,250, 65\u201370. https:\/\/doi.org\/10.1016\/j.psychres.2017.01.064","journal-title":"Psychiatry Research"},{"key":"10204_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/eip.12683","volume":"13","author":"K Thien","year":"2019","unstructured":"Thien, K., & O\u2019Donoghue, B. (2019). Delays and barriers to the commencement of clozapine in eligible people with a psychotic disorder: A literature review. Early Intervention in Psychiatry,13, 18\u201323. https:\/\/doi.org\/10.1111\/eip.12683","journal-title":"Early Intervention in Psychiatry"},{"key":"10204_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.815151","volume":"12","author":"L He","year":"2022","unstructured":"He, L., Yu, Y., Wei, Y., Huang, J., Shen, Y., & Li, H. (2022). Characteristics and spectrum of cardiotoxicity induced by various antipsychotics: A real-world study from 2015 to 2020 based on FAERS. Frontiers in Pharmacology,12, Article Article 815151. https:\/\/doi.org\/10.3389\/fphar.2021.815151","journal-title":"Frontiers in Pharmacology"},{"key":"10204_CR16","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1161\/CIR.0000000000000426","volume":"134","author":"RL Page","year":"2016","unstructured":"Page, R. L., O\u2019Bryant, C. L., Cheng, D., Dow, T. J., Ky, B., Stein, C. M., Spencer, A. P., Trupp, R. J., & Lindenfeld, J. (2016). Drugs that may cause or exacerbate heart failure. Circulation,134, e32-69. https:\/\/doi.org\/10.1161\/CIR.0000000000000426","journal-title":"Circulation"},{"key":"10204_CR17","doi-asserted-by":"publisher","first-page":"e214","DOI":"10.1161\/CIR.0000000000000905","volume":"142","author":"JE Tisdale","year":"2020","unstructured":"Tisdale, J. E., Chung, M. K., Campbell, K. B., Hammadah, M., Joglar, J. A., Leclerc, J., & Rajagopalan, B. (2020). Drug-induced arrhythmias: A scientific statement from the American Heart Association. Circulation,142, e214-233. https:\/\/doi.org\/10.1161\/CIR.0000000000000905","journal-title":"Circulation"},{"key":"10204_CR18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s40263-025-01177-5","volume":"39","author":"S Every-Palmer","year":"2025","unstructured":"Every-Palmer, S., Northwood, K., Tsakas, J., Burrage, M. K., & Siskind, D. (2025). Clozapine-related tachycardia: An analysis of incidence. CNS Drugs,39, 597\u2013607. https:\/\/doi.org\/10.1007\/s40263-025-01177-5","journal-title":"CNS Drugs"},{"key":"10204_CR19","doi-asserted-by":"publisher","unstructured":"Pinioti, E., Glarou, E., Lappas, A.S., Fober, I., Helfer, B., Siafis, S., Christodoulou, N., Nikolakopoulou, A., Leucht, S. and Samara, M. (2025). Examining the safety profile of clozapine versus other antipsychotics: Systematic review and meta-analysis. The British Journal of Psychiatry: 1\u201310. https:\/\/doi.org\/10.1192\/bjp.2025.10421","DOI":"10.1192\/bjp.2025.10421"},{"key":"10204_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000026512","volume":"38","author":"MW Agelink","year":"1998","unstructured":"Agelink, M. W., Malessa, R., Kamcili, E., Zeit, T., Lemmer, W., Bertling, R., & Klieser, E. (1998). Cardiovascular autonomic reactivity in schizophrenics under neuroleptic treatment: A potential predictor of short-term outcome? Neuropsychobiology,38, 19\u201324. https:\/\/doi.org\/10.1159\/000026512","journal-title":"Neuropsychobiology"},{"key":"10204_CR21","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/0006-3223(94)90026-4","volume":"35","author":"T Rechlin","year":"1994","unstructured":"Rechlin, T., Claus, D., & Weis, M. (1994). Heart rate variability in schizophrenic patients and changes of autonomic heart rate parameters during treatment with clozapine. Biological Psychiatry,35, 888\u2013892. https:\/\/doi.org\/10.1016\/0006-3223(94)90026-4","journal-title":"Biological Psychiatry"},{"key":"10204_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0006-3223(93)90250-H","volume":"34","author":"TP Zahn","year":"1993","unstructured":"Zahn, T. P., & Pickar, D. (1993). Autonomic effects of clozapine in schizophrenia: Comparison with placebo and fluphenazine. Biological Psychiatry,34, 3\u201312. https:\/\/doi.org\/10.1016\/0006-3223(93)90250-H","journal-title":"Biological Psychiatry"},{"key":"10204_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00203","volume":"12","author":"JWY Yuen","year":"2018","unstructured":"Yuen, J. W. Y., Kim, D. D., Procyshyn, R. M., White, R. F., Honer, W. G., & Barr, A. M. (2018). Clozapine-induced cardiovascular side effects and autonomic dysfunction: A systematic review. Frontiers in Neuroscience,12, Article Article 203. https:\/\/doi.org\/10.3389\/fnins.2018.00203","journal-title":"Frontiers in Neuroscience"},{"key":"10204_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2045125320937908","volume":"10","author":"TRE Barnes","year":"2020","unstructured":"Barnes, T. R. E., MacCabe, J. H., Kane, J. M., Delgado, O., & Paton, C. (2020). The physical health and side-effect monitoring of patients prescribed clozapine: Data from a clinical audit conducted in UK mental health services. Therapeutic Advances in Psychopharmacology,10, 1\u201310. https:\/\/doi.org\/10.1177\/2045125320937908","journal-title":"Therapeutic Advances in Psychopharmacology"},{"key":"10204_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.schres.2018.03.006","volume":"199","author":"KN Knoph","year":"2018","unstructured":"Knoph, K. N., Morgan, R. J., Palmer, B. A., Schak, K. M., Owen, A. C., Leloux, M. R., Patel, M., & Leung, J. G. (2018). Clozapine-induced cardiomyopathy and myocarditis monitoring: A systematic review. Schizophrenia Research,199, 17\u201330. https:\/\/doi.org\/10.1016\/j.schres.2018.03.006","journal-title":"Schizophrenia Research"},{"key":"10204_CR26","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ijcard.2017.12.102","volume":"259","author":"BL Bellissima","year":"2018","unstructured":"Bellissima, B. L., Tingle, M. D., Cicovi\u0107, A., Alawami, M., & Kenedi, C. (2018). A systematic review of clozapine-induced myocarditis. International Journal of Cardiology,259, 122\u2013129. https:\/\/doi.org\/10.1016\/j.ijcard.2017.12.102","journal-title":"International Journal of Cardiology"},{"key":"10204_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2020.101950","volume":"50","author":"G Kanniah","year":"2020","unstructured":"Kanniah, G., & Kumar, S. (2020). Clozapine associated cardiotoxicity: Issues, challenges and way forward. Asian Journal of Psychiatry,50, Article Article 101950. https:\/\/doi.org\/10.1016\/j.ajp.2020.101950","journal-title":"Asian Journal of Psychiatry"},{"key":"10204_CR28","doi-asserted-by":"publisher","unstructured":"Patel, R.K., Moore, A.M., Piper, S., Sweeney, M., Whiskey, E., Cole, G., Shergill, S.S. and Plymen, C.M. (2019). Clozapine and cardiotoxicity \u2013 A guide for psychiatrists written by cardiologists. Psychiatry Research 282: Article 112491. https:\/\/doi.org\/10.1016\/j.psychres.2019.112491","DOI":"10.1016\/j.psychres.2019.112491"},{"key":"10204_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e13930","volume":"9","author":"P Daniel","year":"2023","unstructured":"Daniel, P., Rajaree, K. M., Rudy, L., Jafor, S., Prasad, S., Avanthika, C., & Jhaveri, S. (2023). Myocarditis in patients on long-term antipsychotics \u2013 Mechanism, management and recent updates. Heliyon,9, Article e13930. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e13930","journal-title":"Heliyon"},{"key":"10204_CR30","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S502312","author":"M Li","year":"2025","unstructured":"Li, M., Bai, Y., Wang, Y., Xing, H., Zhang, Y., Ding, W., Ye, H., Ma, L., Wang, W., & Bao, T. (2025). A review of clinical advances and challenges in clozapine-induced myocarditis. Neuropsychiatric Disease and Treatment. https:\/\/doi.org\/10.2147\/NDT.S502312","journal-title":"Neuropsychiatric Disease and Treatment"},{"key":"10204_CR31","doi-asserted-by":"publisher","first-page":"60","DOI":"10.2174\/1874467215666220211094910","volume":"16","author":"SW Rabkin","year":"2023","unstructured":"Rabkin, S. W., & Tang, J. K. K. (2023). Clozapine-induced myocarditis: Pathophysiologic mechanisms and implications for therapeutic approaches. Current Molecular Pharmacology,16, 60\u201370. https:\/\/doi.org\/10.2174\/1874467215666220211094910","journal-title":"Current Molecular Pharmacology"},{"key":"10204_CR32","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.schres.2023.09.039","volume":"261","author":"N Vaziri","year":"2023","unstructured":"Vaziri, N., Marques, D., Greenway, S. C., & Bousman, C. A. (2023). The cellular mechanism of antipsychotic-induced myocarditis: A systematic review. Schizophrenia Research,261, 206\u2013215. https:\/\/doi.org\/10.1016\/j.schres.2023.09.039","journal-title":"Schizophrenia Research"},{"key":"10204_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2024.131788","volume":"403","author":"BL Bellissima","year":"2024","unstructured":"Bellissima, B. L., Burns, K. E., Helsby, N. A., Kingston, E. L., Garavan, F., & Tingle, M. D. (2024). Clozapine metabolism and cardiotoxicity: A prospective longitudinal study. International Journal of Cardiology,403, Article Article 131788. https:\/\/doi.org\/10.1016\/j.ijcard.2024.131788","journal-title":"International Journal of Cardiology"},{"key":"10204_CR34","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1081\/DMR-120005667","volume":"34","author":"J Uetrecht","year":"2002","unstructured":"Uetrecht, J. (2002). N-oxidation of drugs associated with idiosyncratic drug reactions. Drug Metabolism Reviews,34, 651\u2013665. https:\/\/doi.org\/10.1081\/DMR-120005667","journal-title":"Drug Metabolism Reviews"},{"key":"10204_CR35","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/00498254.2023.2294473","volume":"54","author":"E Kingston","year":"2024","unstructured":"Kingston, E., Tingle, M., Bellissima, B. L., Helsby, N., & Burns, K. (2024). CYP-catalysed cycling of clozapine and clozapine-N-oxide promotes the generation of reactive oxygen species in vitro. Xenobiotica,54, 26\u201337. https:\/\/doi.org\/10.1080\/00498254.2023.2294473","journal-title":"Xenobiotica"},{"key":"10204_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2020.152628","volume":"447","author":"E Arzuk","year":"2021","unstructured":"Arzuk, E., Karaku\u015f, F., & Orhan, H. (2021). Bioactivation of clozapine by mitochondria of the murine heart: Possible cause of cardiotoxicity. Toxicology,447, Article Article 152628. https:\/\/doi.org\/10.1016\/j.tox.2020.152628","journal-title":"Toxicology"},{"key":"10204_CR37","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1021\/tx034035z","volume":"16","author":"DP Williams","year":"2003","unstructured":"Williams, D. P., O\u2019Donnell, C. J. L., Maggs, J. L., Leeder, J. S., Uetrecht, J., Pirmohamed, M., & Park, B. K. (2003). Bioactivation of clozapine by murine cardiac tissue <i>in vivo<\/i> and <i>in vitro<\/i>. Chemical Research in Toxicology,16, 1359\u20131364. https:\/\/doi.org\/10.1021\/tx034035z","journal-title":"Chemical Research in Toxicology"},{"key":"10204_CR38","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.cophys.2017.10.005","volume":"1","author":"H Nakayama","year":"2018","unstructured":"Nakayama, H., & Otsu, K. (2018). Mitochondria and sterile inflammation in the heart. Current Opinion in Physiology,1, 68\u201374. https:\/\/doi.org\/10.1016\/j.cophys.2017.10.005","journal-title":"Current Opinion in Physiology"},{"key":"10204_CR39","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.1093\/eurheartj\/ehaf491","volume":"46","author":"C Maack","year":"2025","unstructured":"Maack, C., Dudek, J., Bertero, E., Tampakakis, E., & Vernon, H. J. (2025). Mitochondrial cardiomyopathies: Pathogenesis, diagnosis, and treatment. European Heart Journal,46, 4060\u20134075. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf491","journal-title":"European Heart Journal"},{"key":"10204_CR40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4088\/JCP.v62n0805","volume":"62","author":"DC Henderson","year":"2001","unstructured":"Henderson, D. C. (2001). Clozapine: Diabetes mellitus, weight gain, and lipid abnormalities. The Journal of Clinical Psychiatry,62, 39\u201344.","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10204_CR41","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/08039488.2017.1334821","volume":"71","author":"O Ingimarsson","year":"2017","unstructured":"Ingimarsson, O., MacCabe, J. H., Haraldsson, M., J\u00f3nsd\u00f3ttir, H., & Sigurdsson, E. (2017). Risk of diabetes and dyslipidemia during clozapine and other antipsychotic drug treatment of schizophrenia in Iceland. Nordic Journal of Psychiatry,71, 496\u2013502. https:\/\/doi.org\/10.1080\/08039488.2017.1334821","journal-title":"Nordic Journal of Psychiatry"},{"key":"10204_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2021.113873","volume":"299","author":"BL Bellissima","year":"2021","unstructured":"Bellissima, B. L., Vara, A., Helsby, N., Garavan, F., & Tingle, M. D. (2021). Incidence and investigation of potential risk-factors for clozapine-associated myocarditis and cardiomyopathy in a New Zealand cohort. Psychiatry Research,299, Article Article 113873. https:\/\/doi.org\/10.1016\/j.psychres.2021.113873","journal-title":"Psychiatry Research"},{"key":"10204_CR43","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ijcard.2017.03.013","volume":"238","author":"AA Khan","year":"2017","unstructured":"Khan, A. A., Ashraf, A., Baker, D., Al-Omary, M. S., Savage, L., Ekmejian, A., Singh, R. S. H., Brienesse, S., Majeed, T., Gordon, T., Drinkwater, V., & Collins, N. J. (2017). Clozapine and incidence of myocarditis and sudden death \u2013 Long term Australian experience. International Journal of Cardiology,238, 136\u2013139. https:\/\/doi.org\/10.1016\/j.ijcard.2017.03.013","journal-title":"International Journal of Cardiology"},{"key":"10204_CR44","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/acps.13398","volume":"145","author":"M Vickers","year":"2022","unstructured":"Vickers, M., Ramineni, V., Malacova, E., Eriksson, L., McMahon, K., Moudgil, V., Scott, J., & Siskind, D. (2022). Risk factors for clozapine-induced myocarditis and cardiomyopathy: A systematic review and meta-analysis. Acta Psychiatrica Scandinavica,145, 442\u2013455. https:\/\/doi.org\/10.1111\/acps.13398","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10204_CR45","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2026.11024","volume":"12","author":"T Easwar","year":"2026","unstructured":"Easwar, T., Chari, D., Abdullah, S., Tollinton, H., Ladinska, E. B. M., & Subramaniam, H. E. (2026). Risk factors for sudden cardiac death or sudden unexplained death in patients treated with clozapine: Systematic review. BJPsych Open,12, Article Article e130. https:\/\/doi.org\/10.1192\/bjo.2026.11024","journal-title":"BJPsych Open"},{"key":"10204_CR46","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.schres.2011.01.017","volume":"128","author":"KJ Ronaldson","year":"2011","unstructured":"Ronaldson, K. J., Fitzgerald, P. B., Taylor, A. J., Topliss, D. J., & McNeil, J. J. (2011). Clinical course and analysis of ten fatal cases of clozapine-induced myocarditis and comparison with 66 surviving cases. Schizophrenia Research,128, 161\u2013165. https:\/\/doi.org\/10.1016\/j.schres.2011.01.017","journal-title":"Schizophrenia Research"},{"key":"10204_CR47","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s40263-017-0461-9","volume":"31","author":"KJ Ronaldson","year":"2017","unstructured":"Ronaldson, K. J. (2017). Cardiovascular disease in clozapine-treated patients: Evidence, mechanisms and management. CNS Drugs,31, 777\u2013795. https:\/\/doi.org\/10.1007\/s40263-017-0461-9","journal-title":"CNS Drugs"},{"key":"10204_CR48","doi-asserted-by":"publisher","unstructured":"De las Cuevas, C., Sanz, E.J. and de Leon, J. (2025). Clozapine-treated patients and myocardial infarction in adults: A pharmacovigilance study in VigiBase interpreted in the context of the literature. Expert Opinion on Drug Safety: 1\u201311. https:\/\/doi.org\/10.1080\/14740338.2025.2518234","DOI":"10.1080\/14740338.2025.2518234"},{"key":"10204_CR49","doi-asserted-by":"publisher","unstructured":"Tseng, P.-T., Chen, Y.-W., Chung, W., Tu, K.-Y., Wang, H.-Y., Wu, C.-K. and Lin, P.-Y. (2016). Significant effect of valproate augmentation therapy in patients with schizophrenia: A meta-analysis study. Medicine 95: Article e2475. https:\/\/doi.org\/10.1097\/MD.0000000000002475","DOI":"10.1097\/MD.0000000000002475"},{"key":"10204_CR50","doi-asserted-by":"publisher","unstructured":"Wang, Y., Xia, J., Helfer, B., Li, C. and Leucht, S. (2016). Valproate for schizophrenia. Cochrane Database of Systematic Reviews: Article CD004028. https:\/\/doi.org\/10.1002\/14651858.CD004028.pub4","DOI":"10.1002\/14651858.CD004028.pub4"},{"key":"10204_CR51","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/2045125311405566","volume":"1","author":"S Varma","year":"2011","unstructured":"Varma, S., Bishara, D., Besag, F. M. C., & Taylor, D. (2011). Clozapine-related EEG changes and seizures: Dose and plasma-level relationships. Therapeutic Advances in Psychopharmacology,1, 47\u201366. https:\/\/doi.org\/10.1177\/2045125311405566","journal-title":"Therapeutic Advances in Psychopharmacology"},{"key":"10204_CR52","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s40263-014-0222-y","volume":"29","author":"AM Williams","year":"2015","unstructured":"Williams, A. M., & Park, S. H. (2015). Seizure associated with clozapine: Incidence, etiology, and management. CNS Drugs,29, 101\u2013111. https:\/\/doi.org\/10.1007\/s40263-014-0222-y","journal-title":"CNS Drugs"},{"key":"10204_CR53","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1081\/CLT-120014645","volume":"40","author":"MD Sztajnkrycer","year":"2002","unstructured":"Sztajnkrycer, M. D. (2002). Valproic acid toxicity: Overview and management. Journal of Toxicology: Clinical Toxicology,40, 789\u2013801. https:\/\/doi.org\/10.1081\/CLT-120014645","journal-title":"Journal of Toxicology: Clinical Toxicology"},{"key":"10204_CR54","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1080\/15376516.2025.2459176","volume":"35","author":"R Kadam","year":"2025","unstructured":"Kadam, R., Palkar, M., & Pingili, R. B. (2025). Mechanisms involved in the valproic acid-induced hepatotoxicity: A comprehensive review. Toxicology Mechanisms and Methods,35, 565\u2013580. https:\/\/doi.org\/10.1080\/15376516.2025.2459176","journal-title":"Toxicology Mechanisms and Methods"},{"key":"10204_CR55","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1055\/s-0032-1323671","volume":"46","author":"MM Schmid","year":"2013","unstructured":"Schmid, M. M., Freudenmann, R. W., Keller, F., Connemann, B. J., Hiemke, C., Gahr, M., Kratzer, W., Fuchs, M., & Sch\u00f6nfeldt-Lecuona, C. (2013). Non-fatal and fatal liver failure associated with valproic acid. Pharmacopsychiatry,46, 63\u201368. https:\/\/doi.org\/10.1055\/s-0032-1323671","journal-title":"Pharmacopsychiatry"},{"key":"10204_CR56","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1080\/17425255.2018.1539077","volume":"14","author":"R Teschke","year":"2018","unstructured":"Teschke, R. (2018). Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method. Expert Opinion on Drug Metabolism & Toxicology,14, 1169\u20131187. https:\/\/doi.org\/10.1080\/17425255.2018.1539077","journal-title":"Expert Opinion on Drug Metabolism & Toxicology"},{"key":"10204_CR57","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/FPC.0b013e32835ea0b2","volume":"23","author":"Y Ghodke-Puranik","year":"2013","unstructured":"Ghodke-Puranik, Y., Thorn, C. F., Lamba, J. K., Leeder, J. S., Song, W., Birnbaum, A. K., Altman, R. B., & Klein, T. E. (2013). Valproic acid pathway: Pharmacokinetics and pharmacodynamics. Pharmacogenetics and Genomics,23, 236\u2013241. https:\/\/doi.org\/10.1097\/FPC.0b013e32835ea0b2","journal-title":"Pharmacogenetics and Genomics"},{"key":"10204_CR58","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0009-2797(94)90014-0","volume":"90","author":"K Kassahun","year":"1994","unstructured":"Kassahun, K., Hu, P., Grillo, M. P., Davis, M. R., Jin, L., & Baillie, T. A. (1994). Metabolic activation of unsaturated derivatives of valproic acid. Identification of novel glutathione adducts formed through coenzyme A-dependent and -independent processes. Chemico-Biological Interactions,90, 253\u2013275. https:\/\/doi.org\/10.1016\/0009-2797(94)90014-0","journal-title":"Chemico-Biological Interactions"},{"key":"10204_CR59","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1016\/0006-2952(92)90324-C","volume":"43","author":"S Ponchaut","year":"1992","unstructured":"Ponchaut, S., Van Hoof, F., & Veitch, K. (1992). In vitro effects of valproate and valproate metabolites on mitochondrial oxidations: Relevance of CoA sequestration to the observed inhibitions. Biochemical Pharmacology,43, 2435\u20132442. https:\/\/doi.org\/10.1016\/0006-2952(92)90324-C","journal-title":"Biochemical Pharmacology"},{"key":"10204_CR60","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/0024-3205(85)90367-4","volume":"36","author":"JH Thurston","year":"1985","unstructured":"Thurston, J. H., Carroll, J. E., Hauhart, R. E., & Schiro, J. A. (1985). A single therapeutic dose of valproate affects liver carbohydrate, fat, adenylate, amino acid, coenzyme A, and carnitine metabolism in infant mice: Possible clinical significance. Life Sciences,36, 1643\u20131651. https:\/\/doi.org\/10.1016\/0024-3205(85)90367-4","journal-title":"Life Sciences"},{"key":"10204_CR61","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/0891-5849(94)90092-2","volume":"17","author":"Y Chen","year":"1994","unstructured":"Chen, Y., Saari, J. T., & Kang, Y. J. (1994). Weak antioxidant defenses make the heart a target for damage in copper-deficient rats. Free Radical Biology & Medicine,17, 529\u2013536. https:\/\/doi.org\/10.1016\/0891-5849(94)90092-2","journal-title":"Free Radical Biology & Medicine"},{"key":"10204_CR62","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.nucmedbio.2013.06.007","volume":"40","author":"SW Kim","year":"2013","unstructured":"Kim, S. W., Hooker, J. M., Otto, N., Win, K., Muench, L., Shea, C., Carter, P., King, P., Reid, A. E., Volkow, N. D., & Fowler, J. S. (2013). Whole-body pharmacokinetics of HDAC inhibitor drugs, butyric acid, valproic acid and 4-phenylbutyric acid measured with carbon-11 labeled analogs by PET. Nuclear Medicine and Biology,40, 912\u2013918. https:\/\/doi.org\/10.1016\/j.nucmedbio.2013.06.007","journal-title":"Nuclear Medicine and Biology"},{"key":"10204_CR63","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001507","author":"RL Smith","year":"2022","unstructured":"Smith, R. L., Wollmann, B. M., Kylles\u00f8, L., Tran, T. T. A., Tveito, M., & Molden, E. (2022). Effect of valproic acid on the metabolic spectrum of clozapine in patients with schizophrenia. Journal of Clinical Psychopharmacology. https:\/\/doi.org\/10.1097\/JCP.0000000000001507","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10204_CR64","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/iub.241","volume":"61","author":"KR Chaudhary","year":"2009","unstructured":"Chaudhary, K. R., Batchu, S. N., & Seubert, J. M. (2009). Cytochrome P450 enzymes and the heart. IUBMB Life,61, 954\u2013960. https:\/\/doi.org\/10.1002\/iub.241","journal-title":"IUBMB Life"},{"key":"10204_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2018.00068","volume":"5","author":"QG Karwi","year":"2018","unstructured":"Karwi, Q. G., Uddin, G. M., Ho, K. L., & Lopaschuk, G. D. (2018). Loss of metabolic flexibility in the failing heart. Frontiers in Cardiovascular Medicine,5, Article Article 68. https:\/\/doi.org\/10.3389\/fcvm.2018.00068","journal-title":"Frontiers in Cardiovascular Medicine"},{"key":"10204_CR66","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1161\/CIRCULATIONAHA.122.062166","volume":"148","author":"WD Watson","year":"2023","unstructured":"Watson, W. D., Green, P. G., Lewis, A. J. M., Arvidsson, P., De Maria, G. L., Arheden, H., Heiberg, E., Clarke, W. T., Rodgers, C. T., Valkovi\u010d, L., Neubauer, S., Herring, N., & Rider, O. J. (2023). Retained metabolic flexibility of the failing human heart. Circulation,148, 109\u2013123. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.062166","journal-title":"Circulation"},{"key":"10204_CR67","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.seizure.2017.03.007","volume":"48","author":"HS Sidhu","year":"2017","unstructured":"Sidhu, H. S., Srinivas, R., & Sadhotra, A. (2017). Evaluate the effects of long-term valproic acid treatment on metabolic profiles in newly diagnosed or untreated female epileptic patients: A prospective study. Seizure - European Journal of Epilepsy,48, 15\u201321. https:\/\/doi.org\/10.1016\/j.seizure.2017.03.007","journal-title":"Seizure - European Journal of Epilepsy"},{"key":"10204_CR68","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1046\/j.1528-1157.2002.31501.x","volume":"43","author":"V Pylv\u00e4nen","year":"2002","unstructured":"Pylv\u00e4nen, V., Knip, M., Pakarinen, A., Kotila, M., Turkka, J., & Isoj\u00e4rvi, J. I. T. (2002). Serum insulin and leptin levels in valproate-associated obesity. Epilepsia,43, 514\u2013517. https:\/\/doi.org\/10.1046\/j.1528-1157.2002.31501.x","journal-title":"Epilepsia"},{"key":"10204_CR69","doi-asserted-by":"publisher","first-page":"H742","DOI":"10.1152\/ajpheart.1994.267.2.H742","volume":"267","author":"MF Allard","year":"1994","unstructured":"Allard, M. F., Schonekess, B. O., Henning, S. L., English, D. R., & Lopaschuk, G. D. (1994). Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. American Journal of Physiology, Heart and Circulatory Physiology,267, H742\u2013H750. https:\/\/doi.org\/10.1152\/ajpheart.1994.267.2.H742","journal-title":"American Journal of Physiology, Heart and Circulatory Physiology"},{"key":"10204_CR70","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1080\/01480545.2020.1850758","volume":"45","author":"R Ahangari","year":"2022","unstructured":"Ahangari, R., Khezri, S., Jahedsani, A., Bakhshii, S., & Salimi, A. (2022). Ellagic acid alleviates clozapine-induced oxidative stress and mitochondrial dysfunction in cardiomyocytes. Drug and Chemical Toxicology,45, 1625\u20131633. https:\/\/doi.org\/10.1080\/01480545.2020.1850758","journal-title":"Drug and Chemical Toxicology"},{"key":"10204_CR71","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/ddr.21790","volume":"82","author":"S Bakhshii","year":"2021","unstructured":"Bakhshii, S., Khezri, S., Ahangari, R., Jahedsani, A., & Salimi, A. (2021). Protection of clozapine-induced oxidative stress and mitochondrial dysfunction by kaempferol in rat cardiomyocytes. Drug Development Research,82, 835\u2013843. https:\/\/doi.org\/10.1002\/ddr.21790","journal-title":"Drug Development Research"},{"key":"10204_CR72","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1007\/s00210-021-02095-1","volume":"394","author":"AA Hafez","year":"2021","unstructured":"Hafez, A. A., Jamali, Z., Khezri, S., & Salimi, A. (2021). Thymoquinone reduces mitochondrial damage and death of cardiomyocytes induced by clozapine. Naunyn-Schmiedeberg\u2019s Archives of Pharmacology,394, 1675\u20131684. https:\/\/doi.org\/10.1007\/s00210-021-02095-1","journal-title":"Naunyn-Schmiedeberg''s Archives of Pharmacology"},{"key":"10204_CR73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059012","volume":"8","author":"V Contreras-Shannon","year":"2013","unstructured":"Contreras-Shannon, V., Heart, D. L., Paredes, R. M., Navaira, E., Catano, G., Maffi, S. K., & Walss-Bass, C. (2013). Clozapine-induced mitochondria alterations and inflammation in brain and insulin-responsive cells. PLoS ONE,8, Article e59012. https:\/\/doi.org\/10.1371\/journal.pone.0059012","journal-title":"PLoS ONE"},{"key":"10204_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2025.119967","volume":"1872","author":"M Fiorani","year":"2025","unstructured":"Fiorani, M., Buffi, G., Bagherlou, N., Canonico, B., De Matteis, R., Guidarelli, A., Montanari, M., Battistelli, M., Papa, S., Coppo, L., Cerioni, L., Spina, A., & Cantoni, O. (2025). Clozapine blunts mitochondrial biogenesis in differentiating adipocytes: The increased ATP demand is met via stimulation of electron transport chain expression and activity in residual mitochondria. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research,1872, Article 119967. https:\/\/doi.org\/10.1016\/j.bbamcr.2025.119967","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"10204_CR75","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.bbrc.2015.03.122","volume":"460","author":"E Elmorsy","year":"2015","unstructured":"Elmorsy, E., & Smith, P. A. (2015). Bioenergetic disruption of human micro-vascular endothelial cells by antipsychotics. Biochemical and Biophysical Research Communications,460, 857\u2013862. https:\/\/doi.org\/10.1016\/j.bbrc.2015.03.122","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10204_CR76","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s00702-012-0782-2","volume":"119","author":"A Ota","year":"2012","unstructured":"Ota, A., Nakashima, A., Kaneko, Y. S., Mori, K., Nagasaki, H., Takayanagi, T., Itoh, M., Kondo, K., Nagatsu, T., & Ota, M. (2012). Effects of aripiprazole and clozapine on the treatment of glycolytic carbon in PC12 cells. Journal of Neural Transmission,119, 1327\u20131342. https:\/\/doi.org\/10.1007\/s00702-012-0782-2","journal-title":"Journal of Neural Transmission"},{"key":"10204_CR77","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1055\/a-2860-7861","volume":"59","author":"XM Hart","year":"2026","unstructured":"Hart, X. M., Gr\u00fcnder, G., Hiemke, C., Adamovic, I., Amann, F., Baumann, P., Bergemann, N., Brandt, C., Clement, H. W., Conca, A., Deckert, J., Dietmaier, O., Eckermann, G., Egberts, K., Endres, K., Erlacher, N., Fekete, S., Ferrea, S., Florio, V., \u2026 Schoretsanitis, G. (2026). Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: Update 2026 - Pharmacokinetic, pharmacogenetic and clinical aspects. Pharmacopsychiatry,59, 166\u2013295. https:\/\/doi.org\/10.1055\/a-2860-7861","journal-title":"Pharmacopsychiatry"},{"key":"10204_CR78","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.arcmed.2019.01.004","volume":"49","author":"S Chaudhary","year":"2018","unstructured":"Chaudhary, S., & Parvez, S. (2018). Valproic acid induced neurotoxicological manifestations and its mitigation by melatonin in rat brain synaptosomes. Archives of Medical Research,49, 441\u2013450. https:\/\/doi.org\/10.1016\/j.arcmed.2019.01.004","journal-title":"Archives of Medical Research"},{"key":"10204_CR79","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.neuroscience.2007.06.053","volume":"149","author":"PS Chen","year":"2007","unstructured":"Chen, P. S., Wang, C. C., Bortner, C. D., Peng, G. S., Wu, X., Pang, H., Lu, R. B., Gean, P. W., Chuang, D. M., & Hong, J. S. (2007). Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity. Neuroscience,149, 203\u2013212. https:\/\/doi.org\/10.1016\/j.neuroscience.2007.06.053","journal-title":"Neuroscience"},{"key":"10204_CR80","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/neuonc\/nop005","volume":"12","author":"J Fu","year":"2010","unstructured":"Fu, J., Shao, C.-J., Chen, F.-R., Ng, H.-K., & Chen, Z.-P. (2010). Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines. Neuro-Oncology,12, 328\u2013340. https:\/\/doi.org\/10.1093\/neuonc\/nop005","journal-title":"Neuro-Oncology"},{"key":"10204_CR81","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.3892\/or.2013.2747","volume":"30","author":"BR Han","year":"2013","unstructured":"Han, B. R., You, B. R., & Park, W. H. (2013). Valproic acid inhibits the growth of HeLa cervical cancer cells via caspase-dependent apoptosis. Oncology Reports,30, 2999\u20133005. https:\/\/doi.org\/10.3892\/or.2013.2747","journal-title":"Oncology Reports"},{"key":"10204_CR82","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/nep.13012","volume":"23","author":"R Heidari","year":"2018","unstructured":"Heidari, R., Jafari, F., Khodaei, F., Shirazi Yeganeh, B., & Niknahad, H. (2018). Mechanism of valproic acid-induced Fanconi syndrome involves mitochondrial dysfunction and oxidative stress in rat kidney. Nephrology,23, 351\u2013361. https:\/\/doi.org\/10.1111\/nep.13012","journal-title":"Nephrology"},{"key":"10204_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/biom15040588","author":"L Tikhonova","year":"2025","unstructured":"Tikhonova, L., Maevsky, E., Montoliu, C., & Kosenko, E. (2025). Valproate damaging effect on erythrocyte metabolism as a decisive factor in the development of encephalopathy. Biomolecules. https:\/\/doi.org\/10.3390\/biom15040588","journal-title":"Biomolecules"},{"key":"10204_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2021.115555","volume":"422","author":"L Zhou","year":"2021","unstructured":"Zhou, L., Zeng, X., Rao, T., Tan, Z., Zhou, G., Ouyang, D., & Chen, L. (2021). Evaluating the protective effects of individual or combined ginsenoside compound K and the downregulation of soluble epoxide hydrolase expression against sodium valproate-induced liver cell damage. Toxicology and Applied Pharmacology,422, Article Article 115555. https:\/\/doi.org\/10.1016\/j.taap.2021.115555","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10204_CR85","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/S0006-291X(83)80205-8","volume":"115","author":"FX Coud\u00e9","year":"1983","unstructured":"Coud\u00e9, F. X., Grimber, G., Pelet, A., & Benoit, Y. (1983). Action of the antiepileptic drug, valproic acid, on fatty acid oxidation in isolated rat hepatocytes. Biochemical and Biophysical Research Communications,115, 730\u2013736. https:\/\/doi.org\/10.1016\/S0006-291X(83)80205-8","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10204_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/cells10102522","author":"E-H Jang","year":"2021","unstructured":"Jang, E.-H., Lee, J.-H., & Kim, S.-A. (2021). Acute valproate exposure induces mitochondrial biogenesis and autophagy with FOXO3a modulation in SH-SY5Y cells. Cells. https:\/\/doi.org\/10.3390\/cells10102522","journal-title":"Cells"},{"key":"10204_CR87","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0920-1211(01)00308-4","volume":"47","author":"CU Johannessen","year":"2001","unstructured":"Johannessen, C. U., Petersen, D., Fonnum, F., & Hassel, B. (2001). The acute effect of valproate on cerebral energy metabolism in mice. Epilepsy Research,47, 247\u2013256. https:\/\/doi.org\/10.1016\/S0920-1211(01)00308-4","journal-title":"Epilepsy Research"},{"key":"10204_CR88","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.tox.2015.03.001","volume":"331","author":"T Komulainen","year":"2015","unstructured":"Komulainen, T., Lodge, T., Hinttala, R., Bolszak, M., Pietil\u00e4, M., Koivunen, P., Hakkola, J., Poulton, J., Morten, K. J., & Uusimaa, J. (2015). Sodium valproate induces mitochondrial respiration dysfunction in HepG2 in vitro cell model. Toxicology,331, 47\u201356. https:\/\/doi.org\/10.1016\/j.tox.2015.03.001","journal-title":"Toxicology"},{"key":"10204_CR89","doi-asserted-by":"publisher","unstructured":"Gnaiger, E. (2020). Mitochondrial physiology. Bioenergetics Communications 2020. https:\/\/doi.org\/10.26124\/bec:2020-0001.v1","DOI":"10.26124\/bec:2020-0001.v1"},{"key":"10204_CR90","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.mam.2004.03.001","volume":"25","author":"MR Duchen","year":"2004","unstructured":"Duchen, M. R. (2004). Mitochondria in health and disease: Perspectives on a new mitochondrial biology. Molecular Aspects of Medicine,25, 365\u2013451. https:\/\/doi.org\/10.1016\/j.mam.2004.03.001","journal-title":"Molecular Aspects of Medicine"},{"key":"10204_CR91","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ana.410330516","volume":"33","author":"C Burkhardt","year":"1993","unstructured":"Burkhardt, C., Kelly, J. P., Lim, Y.-H., Filley, C. M., & Parker, W. D., Jr. (1993). Neuroleptic medications inhibit complex I of the electron transport chain. Annals of Neurology,33, 512\u2013517. https:\/\/doi.org\/10.1002\/ana.410330516","journal-title":"Annals of Neurology"},{"key":"10204_CR92","doi-asserted-by":"publisher","unstructured":"Casademont, J., Garrabou, G., Mir\u00f3, \u00d2., L\u00f3pez, S., Pons, A., Bernardo, M. and Cardellach, F. (2007). Neuroleptic treatment effect on mitochondrial electron transport chain: Peripheral blood mononuclear cells analysis in psychotic patients. Journal of Clinical Psychopharmacology 27. https:\/\/doi.org\/10.1097\/JCP.0b013e318054753e","DOI":"10.1097\/JCP.0b013e318054753e"},{"key":"10204_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxrep.2025.101990","volume":"14","author":"A Groenewald","year":"2025","unstructured":"Groenewald, A., Burns, K. E., Tingle, M. D., Ward, M.-L., & Power, A. S. (2025). Acute exposure to clozapine and sodium valproate impairs oxidative phosphorylation in human cardiac mitochondria. Toxicology Reports,14, Article Article 101990. https:\/\/doi.org\/10.1016\/j.toxrep.2025.101990","journal-title":"Toxicology Reports"},{"key":"10204_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120976","volume":"309","author":"S Du","year":"2022","unstructured":"Du, S., Wang, X., Hu, Y., Zhang, S., Wang, D., Zhang, Q., & Liu, S. (2022). Valproic acid regulates MIEF1 through MST2-HIPPO to suppress breast cancer growth. Life Sciences,309, Article Article 120976. https:\/\/doi.org\/10.1016\/j.lfs.2022.120976","journal-title":"Life Sciences"},{"key":"10204_CR95","doi-asserted-by":"publisher","unstructured":"Killer, M.C., Nold, P., Henkenius, K., Fritz, L., Riedlinger, T., Barckhausen, C., Frech, M., Hackstein, H., Neubauer, A. and Brendel, C. (2017). Immunosuppressive capacity of mesenchymal stem cells correlates with metabolic activity and can be enhanced by valproic acid. Stem Cell Research & Therapy 8: Article 100. https:\/\/doi.org\/10.1186\/s13287-017-0553-y","DOI":"10.1186\/s13287-017-0553-y"},{"key":"10204_CR96","doi-asserted-by":"publisher","unstructured":"Horonyova, P., Durisova, I., Cermakova, P., Babelova, L., Buckova, B., Sofrankova, L., Valachovic, M., Hsu, Y.-H.H. and Balazova, M. (2024). The subtherapeutic dose of valproic acid induces the activity of cardiolipin-dependent proteins. Biochimica et Biophysica Acta (BBA) - Bioenergetics 1865: Article 149501. https:\/\/doi.org\/10.1016\/j.bbabio.2024.149501","DOI":"10.1016\/j.bbabio.2024.149501"},{"key":"10204_CR97","doi-asserted-by":"publisher","unstructured":"Salsaa, M., Pereira, B., Liu, J., Yu, W., Jadhav, S., H\u00fcttemann, M. and Greenberg, M.L. (2020). Valproate inhibits mitochondrial bioenergetics and increases glycolysis in Saccharomyces cerevisiae. Scientific Reports 10: Article 11785. https:\/\/doi.org\/10.1038\/s41598-020-68725-5","DOI":"10.1038\/s41598-020-68725-5"},{"key":"10204_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/cells13161349","author":"D Camussi","year":"2024","unstructured":"Camussi, D., Naef, V., Brogi, L., Della Vecchia, S., Marchese, M., Nicoletti, F., Santorelli, F. M., & Licitra, R. (2024). Delving into the complexity of valproate-induced autism spectrum disorder: The use of zebrafish models. Cells. https:\/\/doi.org\/10.3390\/cells13161349","journal-title":"Cells"},{"key":"10204_CR99","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s00210-019-01791-3","volume":"393","author":"T Cik\u00e1nkov\u00e1","year":"2020","unstructured":"Cik\u00e1nkov\u00e1, T., Fi\u0161ar, Z., & Hroudov\u00e1, J. (2020). In vitro effects of antidepressants and mood-stabilizing drugs on cell energy metabolism. Naunyn-Schmiedeberg\u2019s Archives of Pharmacology,393, 797\u2013811. https:\/\/doi.org\/10.1007\/s00210-019-01791-3","journal-title":"Naunyn-Schmiedeberg''s Archives of Pharmacology"},{"key":"10204_CR100","first-page":"336","volume":"31","author":"J Hroudova","year":"2010","unstructured":"Hroudova, J., & Fisar, Z. (2010). Activities of respiratory chain complexes and citrate synthase influenced by pharmacologically different antidepressants and mood stabilizers. Neuro Endocrinology Letters,31, 336\u2013342.","journal-title":"Neuro Endocrinology Letters"},{"key":"10204_CR101","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.pbb.2012.09.010","volume":"103","author":"G Feier","year":"2013","unstructured":"Feier, G., Valvassori, S. S., Varela, R. B., Resende, W. R., Bavaresco, D. V., Morais, M. O., Scaini, G., Andersen, M. L., Streck, E. L., & Quevedo, J. (2013). Lithium and valproate modulate energy metabolism in an animal model of mania induced by methamphetamine. Pharmacology, Biochemistry and Behavior,103, 589\u2013596. https:\/\/doi.org\/10.1016\/j.pbb.2012.09.010","journal-title":"Pharmacology, Biochemistry and Behavior"},{"key":"10204_CR102","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/15622975.2020.1755450","volume":"22","author":"CC Bortolasci","year":"2021","unstructured":"Bortolasci, C. C., Spolding, B., Kidnapillai, S., Richardson, M. F., Vasilijevic, N., Martin, S. D., Gray, L. J., McGee, S. L., Berk, M., & Walder, K. (2021). Effects of psychoactive drugs on cellular bioenergetic pathways. World Journal of Biological Psychiatry,22, 79\u201393. https:\/\/doi.org\/10.1080\/15622975.2020.1755450","journal-title":"World Journal of Biological Psychiatry"},{"key":"10204_CR103","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3171\/jns.1988.69.4.0568","volume":"69","author":"EL Zager","year":"1988","unstructured":"Zager, E. L., & Ames, A. (1988). Reduction of cellular energy requirements: Screening for agents that may protect against CNS ischemia. Journal of Neurosurgery,69, 568\u2013579. https:\/\/doi.org\/10.3171\/jns.1988.69.4.0568","journal-title":"Journal of Neurosurgery"},{"key":"10204_CR104","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0168-8278(85)80744-3","volume":"1","author":"M Jimenez-Rodriguezvila","year":"1985","unstructured":"Jimenez-Rodriguezvila, M., Caro-Pat\u00f3n, A., Due\u00f1as-Laita, A., Conde, M., Coca, M. C., Martin-Lorente, J. L., Velasco, A., & Mara\u00f1on, A. (1985). Histological, ultrastructural and mitochondrial oxidative phosphorylation studies in liver of rats chronically treated with oral valproic acid. Journal of Hepatology,1, 453\u2013465. https:\/\/doi.org\/10.1016\/S0168-8278(85)80744-3","journal-title":"Journal of Hepatology"},{"key":"10204_CR105","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1096\/fj.201900927RR","volume":"34","author":"C Pirozzi","year":"2020","unstructured":"Pirozzi, C., Lama, A., Annunziata, C., Cavaliere, G., De Caro, C., Citraro, R., Russo, E., Tallarico, M., Iannone, M., Ferrante, M. C., Mollica, M. P., Mattace Raso, G., De Sarro, G., Calignano, A., & Meli, R. (2020). Butyrate prevents valproate-induced liver injury: In vitro and in vivo evidence. FASEB Journal,34, 676\u2013690. https:\/\/doi.org\/10.1096\/fj.201900927RR","journal-title":"FASEB Journal"},{"key":"10204_CR106","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/0006-2952(92)90590-F","volume":"43","author":"S Ponchaut","year":"1992","unstructured":"Ponchaut, S., Van Hoof, F., & Veitch, K. (1992). Cytochrome aa3 depletion is the cause of the deficient mitochondrial respiration induced by chronic valproate administration. Biochemical Pharmacology,43, 644\u2013647. https:\/\/doi.org\/10.1016\/0006-2952(92)90590-F","journal-title":"Biochemical Pharmacology"},{"key":"10204_CR107","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/0022-510X(83)90174-0","volume":"61","author":"L Rumbach","year":"1983","unstructured":"Rumbach, L., Warter, J. M., Rendon, A., Marescaux, C., Micheletti, G., & Waksman, A. (1983). Inhibition of oxidative phosphorylation in hepatic and cerebral mitochondria of sodium valproate-treated rats. Journal of the Neurological Sciences,61, 417\u2013423. https:\/\/doi.org\/10.1016\/0022-510X(83)90174-0","journal-title":"Journal of the Neurological Sciences"},{"key":"10204_CR108","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1016\/0006-2952(90)90248-J","volume":"40","author":"K Veitch","year":"1990","unstructured":"Veitch, K., & Van Hoof, F. (1990). In vitro effects of eight-carbon fatty acids on oxidations in rat liver mitochondria. Biochemical Pharmacology,40, 2153\u20132159. https:\/\/doi.org\/10.1016\/0006-2952(90)90248-J","journal-title":"Biochemical Pharmacology"},{"key":"10204_CR109","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.exger.2010.01.003","volume":"45","author":"MD Brand","year":"2010","unstructured":"Brand, M. D. (2010). The sites and topology of mitochondrial superoxide production. Experimental Gerontology,45, 466\u2013472. https:\/\/doi.org\/10.1016\/j.exger.2010.01.003","journal-title":"Experimental Gerontology"},{"key":"10204_CR110","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/s41418-023-01187-0","volume":"30","author":"P Bernardi","year":"2023","unstructured":"Bernardi, P., Gerle, C., Halestrap, A. P., Jonas, E. A., Karch, J., Mnatsakanyan, N., Pavlov, E., Sheu, S.-S., & Soukas, A. A. (2023). Identity, structure, and function of the mitochondrial permeability transition pore: Controversies, consensus, recent advances, and future directions. Cell Death & Differentiation,30, 1869\u20131885. https:\/\/doi.org\/10.1038\/s41418-023-01187-0","journal-title":"Cell Death & Differentiation"},{"key":"10204_CR111","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1084\/jem.192.7.1001","volume":"192","author":"DB Zorov","year":"2000","unstructured":"Zorov, D. B., Filburn, C. R., Klotz, L.-O., Zweier, J. L., & Sollott, S. J. (2000). Reactive oxygen species (ROS-induced) ROS release: A new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. Journal of Experimental Medicine,192, 1001\u20131014. https:\/\/doi.org\/10.1084\/jem.192.7.1001","journal-title":"Journal of Experimental Medicine"},{"key":"10204_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102915","volume":"67","author":"G Blandino","year":"2023","unstructured":"Blandino, G., Fiorani, M., Canonico, B., De Matteis, R., Guidarelli, A., Montanari, M., Buffi, G., Coppo, L., Arn\u00e9r, E. S. J., & Cantoni, O. (2023). Clozapine suppresses NADPH oxidase activation, counteracts cytosolic H2O2, and triggers early onset mitochondrial dysfunction during adipogenesis of human liposarcoma SW872 cells. Redox Biology,67, Article Article 102915. https:\/\/doi.org\/10.1016\/j.redox.2023.102915","journal-title":"Redox Biology"},{"key":"10204_CR113","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.pbb.2004.05.018","volume":"78","author":"M Polydoro","year":"2004","unstructured":"Polydoro, M., Schr\u00f6der, N., Lima, M. N. M., Caldana, F., Laranja, D. C., Bromberg, E., Roesler, R., Quevedo, J., Moreira, J. C. F., & Dal-Pizzol, F. (2004). Haloperidol- and clozapine-induced oxidative stress in the rat brain. Pharmacology Biochemistry and Behavior,78, 751\u2013756. https:\/\/doi.org\/10.1016\/j.pbb.2004.05.018","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10204_CR114","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1038\/s41380-025-02935-z","volume":"30","author":"N Vaziri","year":"2025","unstructured":"Vaziri, N., Shutt, T. E., Karim, W., Raedler, T. J., Pantelis, C., Thomas, N., Jayaram, M., Greenway, S. C., & Bousman, C. A. (2025). Examination of mitochondria- and inflammasome-mediated mechanisms of clozapine-induced myocarditis using patient-derived iPSC cardiomyocytes. Molecular Psychiatry,30, 3491\u20133501. https:\/\/doi.org\/10.1038\/s41380-025-02935-z","journal-title":"Molecular Psychiatry"},{"key":"10204_CR115","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jpsychires.2015.04.009","volume":"65","author":"SS Valvassori","year":"2015","unstructured":"Valvassori, S. S., Resende, W. R., Lopes-Borges, J., Mariot, E., Dal-Pont, G. C., Vitto, M. F., Luz, G., de Souza, C. T., & Quevedo, J. (2015). Effects of mood stabilizers on oxidative stress-induced cell death signaling pathways in the brains of rats subjected to the ouabain-induced animal model of mania: Mood stabilizers exert protective effects against ouabain-induced activation of the cell death pathway. Journal of Psychiatric Research,65, 63\u201370. https:\/\/doi.org\/10.1016\/j.jpsychires.2015.04.009","journal-title":"Journal of Psychiatric Research"},{"key":"10204_CR116","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3109\/15376516.2013.821567","volume":"23","author":"I Jafarian","year":"2013","unstructured":"Jafarian, I., Eskandari, M. R., Mashayekhi, V., Ahadpour, M., & Hosseini, M.-J. (2013). Toxicity of valproic acid in isolated rat liver mitochondria. Toxicology Mechanisms and Methods,23, 617\u2013623. https:\/\/doi.org\/10.3109\/15376516.2013.821567","journal-title":"Toxicology Mechanisms and Methods"},{"key":"10204_CR117","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1111\/j.1440-1746.2006.04313.x","volume":"21","author":"SK Natarajan","year":"2006","unstructured":"Natarajan, S. K., Eapen, C. E., Pullimood, A. B., & Balasubramanian, K. A. (2006). Oxidative stress in experimental liver microvesicular steatosis: Role of mitochondria and peroxisomes. Journal of Gastroenterology and Hepatology,21, 1240\u20131249. https:\/\/doi.org\/10.1111\/j.1440-1746.2006.04313.x","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10204_CR118","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1021\/tx00047a006","volume":"8","author":"W Tang","year":"1995","unstructured":"Tang, W., Borel, A. G., Fujimiya, T., & Abbott, F. S. (1995). Fluorinated analogs as mechanistic probes in valproic acid hepatotoxicity: Hepatic microvesicular steatosis and glutathione status. Chemical Research in Toxicology,8, 671\u2013682. https:\/\/doi.org\/10.1021\/tx00047a006","journal-title":"Chemical Research in Toxicology"},{"key":"10204_CR119","doi-asserted-by":"publisher","unstructured":"Chalifoux, O., Sterman, S., Faerman, B., Li, M., Trezza, S., Michalak, M., Agellon, L.B. and Mailloux, R.J. (2025). MitoSNO inhibits mitochondrial hydrogen peroxide generation by \u03b1-ketoglutarate dehydrogenase. Journal of Biological Chemistry 301: Article 108510. https:\/\/doi.org\/10.1016\/j.jbc.2025.108510","DOI":"10.1016\/j.jbc.2025.108510"},{"key":"10204_CR120","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1124\/mol.119.118646","volume":"97","author":"Z Gai","year":"2020","unstructured":"Gai, Z., Krajnc, E., Samodelov, S. L., Visentin, M., & Kullak-Ublick, G. A. (2020). Obeticholic acid ameliorates valproic acid\u2013induced hepatic steatosis and oxidative stress. Molecular Pharmacology,97, 314\u2013323. https:\/\/doi.org\/10.1124\/mol.119.118646","journal-title":"Molecular Pharmacology"},{"key":"10204_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20081386","volume":"417","author":"MP Murphy","year":"2008","unstructured":"Murphy, M. P. (2008). How mitochondria produce reactive oxygen species. Biochemical Journal,417, 1\u201313. https:\/\/doi.org\/10.1042\/BJ20081386","journal-title":"Biochemical Journal"},{"key":"10204_CR122","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1158\/1078-0432.CCR-08-1579","volume":"15","author":"F Vandermeers","year":"2009","unstructured":"Vandermeers, F., Hubert, P., Delvenne, P., Mascaux, C., Grigoriu, B., Burny, A., Scherpereel, A., & Willems, L. (2009). Valproate, in combination with pemetrexed and cisplatin, provides additional efficacy to the treatment of malignant mesothelioma. Clinical Cancer Research,15, 2818\u20132828. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-1579","journal-title":"Clinical Cancer Research"},{"key":"10204_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2022.105393","volume":"83","author":"D Ahn","year":"2022","unstructured":"Ahn, D., Kim, C.-W., Go, R.-E., & Choi, K.-C. (2022). Evaluation of mitochondrial oxidative toxicity in mammalian cardiomyocytes by determining the highly reproducible and reliable increase in mitochondrial superoxides after exposure to therapeutic drugs. Toxicology in Vitro,83, Article Article 105393. https:\/\/doi.org\/10.1016\/j.tiv.2022.105393","journal-title":"Toxicology in Vitro"},{"key":"10204_CR124","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/0002-9343(54)90365-4","volume":"16","author":"RJ Bing","year":"1954","unstructured":"Bing, R. J., Siegel, A., Ungar, I., & Gilbert, M. (1954). Metabolism of the human heart: II. Studies on fat, ketone and amino acid metabolism. The American Journal of Medicine,16, 504\u2013515. https:\/\/doi.org\/10.1016\/0002-9343(54)90365-4","journal-title":"The American Journal of Medicine"},{"key":"10204_CR125","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1152\/physrev.00015.2009","volume":"90","author":"GD Lopaschuk","year":"2010","unstructured":"Lopaschuk, G. D., Ussher, J. R., Folmes, C. D. L., Jaswal, J. S., & Stanley, W. C. (2010). Myocardial fatty acid metabolism in health and disease. Physiological Reviews,90, 207\u2013258. https:\/\/doi.org\/10.1152\/physrev.00015.2009","journal-title":"Physiological Reviews"},{"key":"10204_CR126","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0022-2275(20)39499-2","volume":"12","author":"RP Eaton","year":"1971","unstructured":"Eaton, R. P. (1971). Synthesis of plasma triglycerides in endogenous hypertriglyceridemia. Journal of Lipid Research,12, 491\u2013497. https:\/\/doi.org\/10.1016\/S0022-2275(20)39499-2","journal-title":"Journal of Lipid Research"},{"key":"10204_CR127","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1113\/jphysiol.2004.061473","volume":"558","author":"Y-G Niu","year":"2004","unstructured":"Niu, Y.-G., Hauton, D., & Evans, R. D. (2004). Utilization of triacylglycerol-rich lipoproteins by the working rat heart: Routes of uptake and metabolic fates. The Journal of Physiology,558, 225\u2013237. https:\/\/doi.org\/10.1113\/jphysiol.2004.061473","journal-title":"The Journal of Physiology"},{"key":"10204_CR128","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/cvr\/cvn116","volume":"79","author":"RW Schwenk","year":"2008","unstructured":"Schwenk, R. W., Luiken, J. J. F. P., Bonen, A., & Glatz, J. F. C. (2008). Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease. Cardiovascular Research,79, 249\u2013258. https:\/\/doi.org\/10.1093\/cvr\/cvn116","journal-title":"Cardiovascular Research"},{"key":"10204_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154847","volume":"123","author":"C-H Chen","year":"2021","unstructured":"Chen, C.-H., Leu, S.-J.J., Hsu, C.-P., Pan, C.-C., Shyue, S.-K., & Lee, T.-S. (2021). Atypical antipsychotic drugs deregulate the cholesterol metabolism of macrophage-foam cells by activating NOX-ROS-PPAR\u03b3-CD36 signaling pathway. Metabolism,123, Article Article 154847. https:\/\/doi.org\/10.1016\/j.metabol.2021.154847","journal-title":"Metabolism"},{"key":"10204_CR130","doi-asserted-by":"publisher","unstructured":"Wang, K.-C., Chan, H.-Y., Yang, W.-S., Huang, Y.-M., Ho, Y.-F. and Hwang, T.-J. (2024). Cardiometabolic biomarkers and comorbid metabolic syndrome in schizophrenia: A cross-sectional study of long-term clozapine\/olanzapine users. Asian Journal of Psychiatry 102: Articles 104244. https:\/\/doi.org\/10.1016\/j.ajp.2024.104244","DOI":"10.1016\/j.ajp.2024.104244"},{"key":"10204_CR131","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jpsychires.2015.10.008","volume":"72","author":"D L\u00f6ffler","year":"2016","unstructured":"L\u00f6ffler, D., Landgraf, K., K\u00f6rner, A., Kratzsch, J., Kirkby, K. C., & Himmerich, H. (2016). Modulation of triglyceride accumulation in adipocytes by psychopharmacological agents in vitro. Journal of Psychiatric Research,72, 37\u201342. https:\/\/doi.org\/10.1016\/j.jpsychires.2015.10.008","journal-title":"Journal of Psychiatric Research"},{"key":"10204_CR132","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1177\/104012371002200106","volume":"22","author":"DC Henderson","year":"2010","unstructured":"Henderson, D. C., Sharma, B., Fan, X., Copeland, P. M., Borba, C. P., Freudenreich, O., Cather, C., Evins, A. E., & Goff, D. C. (2010). Dietary saturated fat intake and glucose metabolism impairments in nondiabetic, nonobese patients with schizophrenia on clozapine or risperidone. Annals of Clinical Psychiatry,22, 33\u201342. https:\/\/doi.org\/10.1177\/104012371002200106","journal-title":"Annals of Clinical Psychiatry"},{"key":"10204_CR133","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.schres.2009.02.006","volume":"110","author":"M Krakowski","year":"2009","unstructured":"Krakowski, M., Czobor, P., & Citrome, L. (2009). Weight gain, metabolic parameters, and the impact of race in aggressive inpatients randomized to double-blind clozapine, olanzapine or haloperidol. Schizophrenia Research,110, 95\u2013102. https:\/\/doi.org\/10.1016\/j.schres.2009.02.006","journal-title":"Schizophrenia Research"},{"key":"10204_CR134","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1089\/cap.2007.0089","volume":"18","author":"S Kumra","year":"2008","unstructured":"Kumra, S., Kranzler, H., Gerbino-Rosen, G., Kester, H. M., DeThomas, C., Cullen, K., Regan, J., & Kane, J. M. (2008). Clozapine versus \u201chigh-dose\u201d olanzapine in refractory early-onset schizophrenia: An open-label extension study. Journal of Child and Adolescent Psychopharmacology,18, 307\u2013316. https:\/\/doi.org\/10.1089\/cap.2007.0089","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10204_CR135","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S2215-0366(19)30416-X","volume":"7","author":"T Pillinger","year":"2020","unstructured":"Pillinger, T., McCutcheon, R. A., Vano, L., Mizuno, Y., Arumuham, A., Hindley, G., Beck, K., Natesan, S., Efthimiou, O., Cipriani, A., & Howes, O. D. (2020). Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: A systematic review and network meta-analysis. Lancet Psychiatry,7, 64\u201377. https:\/\/doi.org\/10.1016\/S2215-0366(19)30416-X","journal-title":"Lancet Psychiatry"},{"key":"10204_CR136","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1017\/S1461145705005110","volume":"8","author":"RC Smith","year":"2005","unstructured":"Smith, R. C., Lindenmayer, J.-P., Bark, N., Warner-Cohen, J., Vaidhyanathaswamy, S., & Khandat, A. (2005). Clozapine, risperidone, olanzapine, and conventional antipsychotic drug effects on glucose, lipids, and leptin in schizophrenic patients. International Journal of Neuropsychopharmacology,8, 183\u2013194. https:\/\/doi.org\/10.1017\/S1461145705005110","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10204_CR137","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1055\/s-0028-1100425","volume":"42","author":"A Tschoner","year":"2009","unstructured":"Tschoner, A., Engl, J., Rettenbacher, M., Edlinger, M., Kaser, S., Tatarczyk, T., Effenberger, M., Patsch, J. R., Fleischhacker, W. W., & Ebenbichler, C. F. (2009). Effects of six second generation antipsychotics on body weight and metabolism \u2013 Risk assessment and results from a prospective study. Pharmacopsychiatry,42, 29\u201334. https:\/\/doi.org\/10.1055\/s-0028-1100425","journal-title":"Pharmacopsychiatry"},{"key":"10204_CR138","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1007\/s00213-006-0384-5","volume":"186","author":"R-R Wu","year":"2006","unstructured":"Wu, R.-R., Zhao, J.-P., Liu, Z.-N., Zhai, J.-G., Guo, X.-F., Guo, W.-B., & Tang, J.-S. (2006). Effects of typical and atypical antipsychotics on glucose\u2013insulin homeostasis and lipid metabolism in first-episode schizophrenia. Psychopharmacology (Berl),186, 572\u2013578. https:\/\/doi.org\/10.1007\/s00213-006-0384-5","journal-title":"Psychopharmacology (Berl)"},{"key":"10204_CR139","doi-asserted-by":"publisher","unstructured":"Wu, R.-R., Zhao, J.-P., Zhai, J.-G., Guo, X.-F. and Guo, W.-B. (2007). Sex difference in effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia. Journal of Clinical Psychopharmacology 27. https:\/\/doi.org\/10.1097\/JCP.0b013e3180cac8db","DOI":"10.1097\/JCP.0b013e3180cac8db"},{"key":"10204_CR140","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00213-011-2397-y","volume":"219","author":"G Jassim","year":"2012","unstructured":"Jassim, G., Skrede, S., V\u00e1zquez, M. J., Wergedal, H., Vik-Mo, A. O., Lunder, N., Di\u00e9guez, C., Vidal-Puig, A., Berge, R. K., L\u00f3pez, M., Steen, V. M., & Fern\u00f8, J. (2012). Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in rat. Psychopharmacology (Berl),219, 783\u2013794. https:\/\/doi.org\/10.1007\/s00213-011-2397-y","journal-title":"Psychopharmacology (Berl)"},{"key":"10204_CR141","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02884-w","volume":"7","author":"X Liu","year":"2017","unstructured":"Liu, X., Wu, Z., Lian, J., Hu, C.-H., Huang, X.-F., & Deng, C. (2017). Time-dependent changes and potential mechanisms of glucose-lipid metabolic disorders associated with chronic clozapine or olanzapine treatment in rats. Scientific Reports,7, Article Article 2762. https:\/\/doi.org\/10.1038\/s41598-017-02884-w","journal-title":"Scientific Reports"},{"key":"10204_CR142","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1126\/science.abc8861","volume":"370","author":"D Murashige","year":"2020","unstructured":"Murashige, D., Jang, C., Neinast, M., Edwards, J. J., Cowan, A., Hyman, M. C., Rabinowitz, J. D., Frankel, D. S., & Arany, Z. (2020). Comprehensive quantification of fuel use by the failing and nonfailing human heart. Science,370, 364\u2013368. https:\/\/doi.org\/10.1126\/science.abc8861","journal-title":"Science"},{"key":"10204_CR143","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1007\/s00204-018-2263-3","volume":"92","author":"Y-W Li","year":"2018","unstructured":"Li, Y.-W., Wang, C.-H., Chen, C.-J., Wang, C. C. N., Lin, C.-L., Cheng, W.-K., Shen, H.-Y., & Lim, Y.-P. (2018). Effects of antiepileptic drugs on lipogenic gene regulation and hyperlipidemia risk in Taiwan: A nationwide population-based cohort study and supporting in vitro studies. Archives of Toxicology,92, 2829\u20132844. https:\/\/doi.org\/10.1007\/s00204-018-2263-3","journal-title":"Archives of Toxicology"},{"key":"10204_CR144","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1177\/0883073808318538","volume":"23","author":"HY Tomoum","year":"2008","unstructured":"Tomoum, H. Y., Awadallah, M. M., Fouad, D. A., & Ali, A. H. (2008). Lipid profile, apolipoproteins A and B in children with epilepsy. Journal of Child Neurology,23, 1275\u20131281. https:\/\/doi.org\/10.1177\/0883073808318538","journal-title":"Journal of Child Neurology"},{"key":"10204_CR145","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/aps.2013.135","volume":"35","author":"L-f Zhang","year":"2014","unstructured":"Zhang, L.-f, Liu, L.-s, Chu, X.-m, Xie, H., Cao, L.-j, Guo, C., A, J.-y, Cao, B., Li, M.-j, Wang, G.-j, & Hao, H.-p. (2014). Combined effects of a high-fat diet and chronic valproic acid treatment on hepatic steatosis and hepatotoxicity in rats. Acta Pharmacologica Sinica,35, 363\u2013372. https:\/\/doi.org\/10.1038\/aps.2013.135","journal-title":"Acta Pharmacologica Sinica"},{"key":"10204_CR146","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1528-1157.1990.tb05387.x","volume":"31","author":"E Beghi","year":"1990","unstructured":"Beghi, E., Bizzi, A., Codegoni, A. M., Trevisan, D., & Torri, W. (1990). Valproate, carnitine metabolism, and biochemical indicators of liver function. Epilepsia,31, 346\u2013352. https:\/\/doi.org\/10.1111\/j.1528-1157.1990.tb05387.x","journal-title":"Epilepsia"},{"key":"10204_CR147","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/j.1468-1331.2012.03708.x","volume":"19","author":"K Phabphal","year":"2012","unstructured":"Phabphal, K., Limapichat, K., Sathirapanya, P., Setthawatcharawanich, S., & Geater, A. (2012). Characterization of glucose homeostasis and lipid profile in adult, seizure-free, epileptic patients in Asian population. European Journal of Neurology,19, 1228\u20131234. https:\/\/doi.org\/10.1111\/j.1468-1331.2012.03708.x","journal-title":"European Journal of Neurology"},{"key":"10204_CR148","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1212\/WNL.33.10.1348","volume":"33","author":"JH Thurston","year":"1983","unstructured":"Thurston, J. H., Carroll, J. E., Dodson, W. E., Hauhart, R. E., & Tasch, V. (1983). Chronic valproate administration reduces fasting ketonemia in children. Neurology,33, 1348\u20131348. https:\/\/doi.org\/10.1212\/WNL.33.10.1348","journal-title":"Neurology"},{"key":"10204_CR149","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.taap.2018.11.007","volume":"363","author":"W Wang","year":"2019","unstructured":"Wang, W., Bai, M., Jiang, T., Li, C., Li, P., Zhou, H., Wang, Z., Li, L., & Jiang, H. (2019). Clozapine-induced reduction of l-carnitine reabsorption via inhibition\/down-regulation of renal carnitine\/organic cation transporter 2 contributes to liver lipid metabolic disorder in mice. Toxicology and Applied Pharmacology,363, 47\u201356. https:\/\/doi.org\/10.1016\/j.taap.2018.11.007","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10204_CR150","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/9576503","author":"R Chang","year":"2016","unstructured":"Chang, R., Chou, M.-C., Hung, L.-Y., Wang, M.-E., Hsu, M.-C., & Chiu, C.-H. (2016). Study of valproic acid-enhanced hepatocyte steatosis. BioMed Research International. https:\/\/doi.org\/10.1155\/2016\/9576503","journal-title":"BioMed Research International"},{"key":"10204_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2020.152585","volume":"445","author":"L Ma","year":"2020","unstructured":"Ma, L., Wang, Y., Chen, X., Zhao, L., & Guo, Y. (2020). Involvement of CYP2E1-ROS-CD36\/DGAT2 axis in the pathogenesis of VPA-induced hepatic steatosis in vivo and in vitro. Toxicology,445, Article Article 152585. https:\/\/doi.org\/10.1016\/j.tox.2020.152585","journal-title":"Toxicology"},{"key":"10204_CR152","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.toxlet.2021.04.016","volume":"346","author":"L Yan","year":"2021","unstructured":"Yan, L., Yang, K., Wang, S., Xie, Y., Zhang, L., & Tian, X. (2021). PXR-mediated expression of FABP4 promotes valproate-induced lipid accumulation in HepG2 cells. Toxicology Letters,346, 47\u201356. https:\/\/doi.org\/10.1016\/j.toxlet.2021.04.016","journal-title":"Toxicology Letters"},{"key":"10204_CR153","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.113860","volume":"177","author":"D Gr\u00fcnig","year":"2020","unstructured":"Gr\u00fcnig, D., Szabo, L., Marbet, M., & Kr\u00e4henb\u00fchl, S. (2020). Valproic acid affects fatty acid and triglyceride metabolism in HepaRG cells exposed to fatty acids by different mechanisms. Biochemical Pharmacology,177, Article 113860. https:\/\/doi.org\/10.1016\/j.bcp.2020.113860","journal-title":"Biochemical Pharmacology"},{"key":"10204_CR154","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1007\/s00213-018-4960-2","volume":"235","author":"X Bai","year":"2018","unstructured":"Bai, X., Xu, C., Wen, D., Chen, Y., Li, H., Wang, X., Zhou, L., Huang, M., & Jin, J. (2018). Polymorphisms of peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) and cluster of differentiation 36 (CD36) associated with valproate-induced obesity in epileptic patients. Psychopharmacology (Berl),235, 2665\u20132673. https:\/\/doi.org\/10.1007\/s00213-018-4960-2","journal-title":"Psychopharmacology (Berl)"},{"key":"10204_CR155","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/00007691-198712000-00005","volume":"9","author":"G Gatti","year":"1987","unstructured":"Gatti, G., Crema, F., Attardo-Parrinello, G., Fratino, P., Aguzzi, F., & Perucca, E. (1987). Serum protein binding of phenytoin and valproic acid in insulin-dependent diabetes mellitus. Therapeutic Drug Monitoring,9, 389\u2013391. https:\/\/doi.org\/10.1097\/00007691-198712000-00005","journal-title":"Therapeutic Drug Monitoring"},{"key":"10204_CR156","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1172\/JCI10947","volume":"107","author":"H-C Chiu","year":"2001","unstructured":"Chiu, H.-C., Kovacs, A., Ford, D. A., Hsu, F.-F., Garcia, R., Herrero, P., Saffitz, J. E., & Schaffer, J. E. (2001). A novel mouse model of lipotoxic cardiomyopathy. Journal of Clinical Investigation,107, 813\u2013822. https:\/\/doi.org\/10.1172\/JCI10947","journal-title":"Journal of Clinical Investigation"},{"key":"10204_CR157","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2012.00401","volume":"3","author":"J F\u00fcllekrug","year":"2012","unstructured":"F\u00fcllekrug, J., Ehehalt, R., & Poppelreuther, M. (2012). Outlook: Membrane junctions enable the metabolic trapping of fatty acids by intracellular acyl-CoA synthetases. Frontiers in Physiology,3, Article Article 401. https:\/\/doi.org\/10.3389\/fphys.2012.00401","journal-title":"Frontiers in Physiology"},{"key":"10204_CR158","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/j.cmet.2024.06.003","volume":"36","author":"MR Bornstein","year":"2024","unstructured":"Bornstein, M. R., Tian, R., & Arany, Z. (2024). Human cardiac metabolism. Cell Metabolism,36, 1456\u20131481. https:\/\/doi.org\/10.1016\/j.cmet.2024.06.003","journal-title":"Cell Metabolism"},{"key":"10204_CR159","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/0002-9149(77)90166-7","volume":"40","author":"WJ Rogers","year":"1977","unstructured":"Rogers, W. J., Russell, R. O., McDaniel, H. G., & Rackley, C. E. (1977). Acute effects of glucose-insulin-potassium infusion on myocardial substrates, coronary blood flow and oxygen consumption in man. American Journal of Cardiology,40, 421\u2013428. https:\/\/doi.org\/10.1016\/0002-9149(77)90166-7","journal-title":"American Journal of Cardiology"},{"key":"10204_CR160","doi-asserted-by":"publisher","first-page":"32","DOI":"10.2337\/db07-1199","volume":"57","author":"LR Peterson","year":"2008","unstructured":"Peterson, L. R., Herrero, P., McGill, J., Schechtman, K. B., Kisrieva-Ware, Z., Lesniak, D., & Gropler, R. J. (2008). Fatty acids and insulin modulate myocardial substrate metabolism in humans with type 1 diabetes. Diabetes,57, 32\u201340. https:\/\/doi.org\/10.2337\/db07-1199","journal-title":"Diabetes"},{"key":"10204_CR161","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/oby.2011.208","volume":"20","author":"LR Peterson","year":"2012","unstructured":"Peterson, L. R., Saeed, I. M., McGill, J. B., Herrero, P., Schechtman, K. B., Gunawardena, R., Recklein, C. L., Coggan, A. R., DeMoss, A. J., Dence, C. S., & Gropler, R. J. (2012). Sex and type 2 diabetes: Obesity-independent effects on left ventricular substrate metabolism and relaxation in humans. Obesity,20, 802\u2013810. https:\/\/doi.org\/10.1038\/oby.2011.208","journal-title":"Obesity"},{"key":"10204_CR162","doi-asserted-by":"publisher","first-page":"H2158","DOI":"10.1152\/ajpheart.00086.2003","volume":"285","author":"PF Soto","year":"2003","unstructured":"Soto, P. F., Herrero, P., Kates, A. M., Dence, C. S., Ehsani, A. A., D\u00e1vila-Rom\u00e1n, V., Schechtman, K. B., & Gropler, R. J. (2003). Impact of aging on myocardial metabolic response to dobutamine. American Journal of Physiology, Heart and Circulatory Physiology,285, H2158\u2013H2164. https:\/\/doi.org\/10.1152\/ajpheart.00086.2003","journal-title":"American Journal of Physiology, Heart and Circulatory Physiology"},{"key":"10204_CR163","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1016\/S0021-9258(19)63423-X","volume":"237","author":"J Bremer","year":"1962","unstructured":"Bremer, J. (1962). Carnitine in intermediary metabolism: Reversible acetylation of carnitine by mitochondria. Journal of Biological Chemistry,237, 2228\u20132231. https:\/\/doi.org\/10.1016\/S0021-9258(19)63423-X","journal-title":"Journal of Biological Chemistry"},{"key":"10204_CR164","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/S0021-9258(19)45682-2","volume":"247","author":"CL Hoppel","year":"1972","unstructured":"Hoppel, C. L., & Tomec, R. J. (1972). Carnitine palmityltransferase: Location of two enzymatic activities in rat liver mitochondria. Journal of Biological Chemistry,247, 832\u2013841. https:\/\/doi.org\/10.1016\/S0021-9258(19)45682-2","journal-title":"Journal of Biological Chemistry"},{"key":"10204_CR165","doi-asserted-by":"publisher","first-page":"6683","DOI":"10.1016\/S0021-9258(17)32999-X","volume":"251","author":"SV Pande","year":"1976","unstructured":"Pande, S. V., & Parvin, R. (1976). Characterization of carnitine acylcarnitine translocase system of heart mitochondria. Journal of Biological Chemistry,251, 6683\u20136691. https:\/\/doi.org\/10.1016\/S0021-9258(17)32999-X","journal-title":"Journal of Biological Chemistry"},{"key":"10204_CR166","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1042\/bj2950061","volume":"295","author":"MM Awan","year":"1993","unstructured":"Awan, M. M., & Saggerson, E. D. (1993). Malonyl-CoA metabolism in cardiac myocytes and its relevance to the control of fatty acid oxidation. Biochemical Journal,295, 61\u201366. https:\/\/doi.org\/10.1042\/bj2950061","journal-title":"Biochemical Journal"},{"key":"10204_CR167","doi-asserted-by":"publisher","first-page":"H2122","DOI":"10.1152\/ajpheart.1998.275.6.H2122","volume":"275","author":"JRB Dyck","year":"1998","unstructured":"Dyck, J. R. B., Barr, A. J., Barr, R. L., Kolattukudy, P. E., & Lopaschuk, G. D. (1998). Characterization of cardiac malonyl-CoA decarboxylase and its putative role in regulating fatty acid oxidation. American Journal of Physiology, Heart and Circulatory Physiology,275, H2122\u2013H2129. https:\/\/doi.org\/10.1152\/ajpheart.1998.275.6.H2122","journal-title":"American Journal of Physiology, Heart and Circulatory Physiology"},{"key":"10204_CR168","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.lfs.2010.05.017","volume":"87","author":"JH Kim","year":"2010","unstructured":"Kim, J. H., Lee, J. O., Lee, S. K., Jung, J. H., You, G. Y., Park, S. H., Park, M., Kim, S. D., & Kim, H. S. (2010). Clozapine activates AMP-activated protein kinase (AMPK) in C2C12 myotube cells and stimulates glucose uptake. Life Sciences,87, 42\u201348. https:\/\/doi.org\/10.1016\/j.lfs.2010.05.017","journal-title":"Life Sciences"},{"key":"10204_CR169","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1017\/S1461145711000976","volume":"15","author":"MK Kim","year":"2012","unstructured":"Kim, M. K., Kim, S. H., Yu, H. S., Park, H. G., Kang, U. G., Ahn, Y. M., & Kim, Y. S. (2012). The effect of clozapine on the AMPK-ACC-CPT1 pathway in the rat frontal cortex. International Journal of Neuropsychopharmacology,15, 907\u2013917. https:\/\/doi.org\/10.1017\/S1461145711000976","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10204_CR170","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1111\/j.2042-7158.2010.01136.x","volume":"62","author":"F Kasuya","year":"2010","unstructured":"Kasuya, F., Nishizawa, R., Masuyama, T., & Kazumi, M. (2010). Evaluation of a screening method by liquid chromatography-tandem mass spectrometry for estimating effect of drugs on the activation and \u03b2-oxidation of fatty acids in mitochondria. Journal of Pharmacy and Pharmacology,62, 1697\u20131703. https:\/\/doi.org\/10.1111\/j.2042-7158.2010.01136.x","journal-title":"Journal of Pharmacy and Pharmacology"},{"key":"10204_CR171","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/0003-9861(83)90602-1","volume":"223","author":"C-M Becker","year":"1983","unstructured":"Becker, C.-M., & Harris, R. A. (1983). Influence of valproic acid on hepatic carbohydrate and lipid metabolism. Archives of Biochemistry and Biophysics,223, 381\u2013392. https:\/\/doi.org\/10.1016\/0003-9861(83)90602-1","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10204_CR172","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1203\/00006450-199301000-00015","volume":"33","author":"JH Thurston","year":"1993","unstructured":"Thurston, J. H., & Hauhart, R. E. (1993). Reversal of the adverse chronic effects of the unsaturated derivative of valproic acid\u20142-n-propyl-4-pentenoic acid\u2014on ketogenesis and liver coenzyme a metabolism by a single injection of pantothenate, carnitine, and acetylcysteine in developing mice. Pediatric Research,33, 72\u201376. https:\/\/doi.org\/10.1203\/00006450-199301000-00015","journal-title":"Pediatric Research"},{"key":"10204_CR173","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.braindev.2005.11.005","volume":"28","author":"G Coppola","year":"2006","unstructured":"Coppola, G., Epifanio, G., Auricchio, G., Federico, R. R., Resicato, G., & Pascotto, A. (2006). Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet. Brain & Development,28, 358\u2013365. https:\/\/doi.org\/10.1016\/j.braindev.2005.11.005","journal-title":"Brain & Development"},{"key":"10204_CR174","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1055\/s-2008-1071456","volume":"21","author":"B Melegh","year":"1990","unstructured":"Melegh, B., Kerner, J., Acs\u00e1di, G., Lakatos, J., & S\u00e1ndor, A. (1990). L-Carnitine replacement therapy in chronic valproate treatment. Neuropediatrics,21, 40\u201343. https:\/\/doi.org\/10.1055\/s-2008-1071456","journal-title":"Neuropediatrics"},{"key":"10204_CR175","doi-asserted-by":"publisher","first-page":"25","DOI":"10.24953\/turkjpediatr.1995.3535","volume":"37","author":"HB Toksoy","year":"1995","unstructured":"Toksoy, H. B., Tanzer, F. N., & Atalay, A. (1995). Serum carnitine, beta-hydroxybutyrate and ammonia levels during valproic acid therapy. The Turkish Journal of Pediatrics,37, 25\u201329.","journal-title":"The Turkish Journal of Pediatrics"},{"key":"10204_CR176","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1177\/0960327112444477","volume":"31","author":"W Wang","year":"2012","unstructured":"Wang, W., Lin, R., Zhang, J., Mao, Y., Bu, X., Ji, Q., Zhai, X., Lin, Q., Yang, L., & Zhang, K. (2012). Involvement of fatty acid metabolism in the hepatotoxicity induced by divalproex sodium. Human & Experimental Toxicology,31, 1092\u20131101. https:\/\/doi.org\/10.1177\/0960327112444477","journal-title":"Human & Experimental Toxicology"},{"key":"10204_CR177","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0003-9861(82)90450-7","volume":"213","author":"B Davidson","year":"1982","unstructured":"Davidson, B., & Schulz, H. (1982). Separation, properties, and regulation of acyl coenzyme A dehydrogenases from bovine heart and liver. Archives of Biochemistry and Biophysics,213, 155\u2013162. https:\/\/doi.org\/10.1016\/0003-9861(82)90450-7","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10204_CR178","first-page":"390","volume-title":"Methods in enzymology","author":"JC Fong","year":"1981","unstructured":"Fong, J. C., & Schulz, H. (1981). Short-chain and long-chain enoyl-CoA hydratases from pig heart muscle. Methods in enzymology (pp. 390\u2013398). Academic Press."},{"key":"10204_CR179","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1016\/S0021-9258(19)44008-8","volume":"248","author":"BE Noyes","year":"1973","unstructured":"Noyes, B. E., & Bradshaw, R. A. (1973). L-3-Hydroxyacyl coenyzme a dehydrogenase from pig heart muscle: I. Purification and properties. Journal of Biological Chemistry,248, 3052\u20133059. https:\/\/doi.org\/10.1016\/S0021-9258(19)44008-8","journal-title":"Journal of Biological Chemistry"},{"key":"10204_CR180","doi-asserted-by":"publisher","first-page":"7371","DOI":"10.1016\/S0021-9258(19)68972-6","volume":"256","author":"HF Gilbert","year":"1981","unstructured":"Gilbert, H. F., Lennox, B. J., Mossman, C. D., & Carle, W. C. (1981). The relation of acyl transfer to the overall reaction of thiolase I from porcine heart. Journal of Biological Chemistry,256, 7371\u20137377. https:\/\/doi.org\/10.1016\/S0021-9258(19)68972-6","journal-title":"Journal of Biological Chemistry"},{"key":"10204_CR181","first-page":"127","volume-title":"New comprehensive biochemistry","author":"H Schulz","year":"2002","unstructured":"Schulz, H. (2002). Oxidation of fatty acids in eukaryotes. New comprehensive biochemistry (pp. 127\u2013150)"},{"key":"10204_CR182","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev.ph.36.030174.002213","volume":"36","author":"JR Neely","year":"1974","unstructured":"Neely, J. R., & Morgan, H. E. (1974). Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annual Review of Physiology,36, 413\u2013459. https:\/\/doi.org\/10.1146\/annurev.ph.36.030174.002213","journal-title":"Annual Review of Physiology"},{"key":"10204_CR183","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/schbul\/sbq053","volume":"38","author":"VL Albaugh","year":"2012","unstructured":"Albaugh, V. L., Vary, T. C., Ilkayeva, O., Wenner, B. R., Maresca, K. P., Joyal, J. L., Breazeale, S., Elich, T. D., Lang, C. H., & Lynch, C. J. (2012). Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodents. Schizophrenia Bulletin,38, 153\u2013166. https:\/\/doi.org\/10.1093\/schbul\/sbq053","journal-title":"Schizophrenia Bulletin"},{"key":"10204_CR184","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1242\/dmm.008391","volume":"5","author":"LM Elphick","year":"2012","unstructured":"Elphick, L. M., Pawolleck, N., Guschina, I. A., Chaieb, L., Eikel, D., Nau, H., Harwood, J. L., Plant, N. J., & Williams, R. S. B. (2012). Conserved valproic-acid-induced lipid droplet formation in Dictyostelium and human hepatocytes identifies structurally active compounds. Disease Models & Mechanisms,5, 231\u2013240. https:\/\/doi.org\/10.1242\/dmm.008391","journal-title":"Disease Models & Mechanisms"},{"key":"10204_CR185","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1002\/hep.1840040609","volume":"4","author":"JW Kesterson","year":"1984","unstructured":"Kesterson, J. W., Granneman, R. G., & Machinist, J. M. (1984). The hepatotoxicity of valproic acid and its metabolites in rats. I. Toxicologic, biochemical and histopathologic studies. Hepatology,4, 1143\u20131152. https:\/\/doi.org\/10.1002\/hep.1840040609","journal-title":"Hepatology"},{"key":"10204_CR186","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0009-2797(01)00234-4","volume":"137","author":"MFB Silva","year":"2001","unstructured":"Silva, M. F. B., Ruiter, J. P. N., Ijlst, L., Jakobs, C., Duran, M., de Almeida, I. T., & Wanders, R. J. A. (2001). Differential effect of valproate and its \u03942- and \u03944-unsaturated metabolites, on the \u03b2-oxidation rate of long-chain and medium-chain fatty acids. Chemico-Biological Interactions,137, 203\u2013212. https:\/\/doi.org\/10.1016\/S0009-2797(01)00234-4","journal-title":"Chemico-Biological Interactions"},{"key":"10204_CR187","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/0006-2952(83)90054-0","volume":"32","author":"DM Turnbull","year":"1983","unstructured":"Turnbull, D. M., Bone, A. J., Bartlett, K., Koundakjian, P. P., & Sherratt, H. S. A. (1983). The effects of valproate on intermediary metabolism in isolated rat hepatocytes and intact rats. Biochemical Pharmacology,32, 1887\u20131892. https:\/\/doi.org\/10.1016\/0006-2952(83)90054-0","journal-title":"Biochemical Pharmacology"},{"key":"10204_CR188","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0006-291X(85)91014-9","volume":"132","author":"SM Bjorge","year":"1985","unstructured":"Bjorge, S. M., & Baillie, T. A. (1985). Inhibition of medium-chain fatty acid \u03b2-oxidation in vitro by valproic acid and its unsaturated metabolite, 2-n-propyl-4-pentenoic acid. Biochemical and Biophysical Research Communications,132, 245\u2013252. https:\/\/doi.org\/10.1016\/0006-291X(85)91014-9","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10204_CR189","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1139\/y04-096","volume":"82","author":"T Daniels","year":"2004","unstructured":"Daniels, T., Gallagher, M., Tremblay, G., & Rodgers, R. L. (2004). Effects of valproic acid on cardiac metabolism. Canadian Journal of Physiology and Pharmacology,82, 927\u2013933. https:\/\/doi.org\/10.1139\/y04-096","journal-title":"Canadian Journal of Physiology and Pharmacology"},{"key":"10204_CR190","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1023\/A:1020501021222","volume":"30","author":"M Huizing","year":"1998","unstructured":"Huizing, M., Ruitenbeek, W., van den Heuvel, L. P., Dolce, V., Iacobazzi, V., Smeitink, J. A. M., Palmieri, F., & Frans Trijbels, J. M. (1998). Human mitochondrial transmembrane metabolite carriers: Tissue distribution and its implication for mitochondrial disorders. Journal of Bioenergetics and Biomembranes,30, 277\u2013284. https:\/\/doi.org\/10.1023\/A:1020501021222","journal-title":"Journal of Bioenergetics and Biomembranes"},{"key":"10204_CR191","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41586-022-04475-w","volume":"603","author":"PK Arnold","year":"2022","unstructured":"Arnold, P. K., Jackson, B. T., Paras, K. I., Brunner, J. S., Hart, M. L., Newsom, O. J., Alibeckoff, S. P., Endress, J., Drill, E., Sullivan, L. B., & Finley, L. W. S. (2022). A non-canonical tricarboxylic acid cycle underlies cellular identity. Nature,603, 477\u2013481. https:\/\/doi.org\/10.1038\/s41586-022-04475-w","journal-title":"Nature"},{"key":"10204_CR192","doi-asserted-by":"publisher","first-page":"101301","DOI":"10.1016\/j.jacbts.2025.04.015","volume":"10","author":"M Meddeb","year":"2025","unstructured":"Meddeb, M., Koleini, N., Keykhaei, M., Liu, T., Rhodehamel, M., Mandarano, L., Farshidfar, F., Zhao, L., Kwon, S., Keceli, G., Ahmet, I., Paolocci, N., Hahn, V., Sharma, K., Pearce, E. L., & Kass, D. A. (2025). ATP-citrate lyase supports cardiac function and NAD+\/NADH balance and is depressed in human failing myocardium. JACC: Basic to Translational Science,10, 101301. https:\/\/doi.org\/10.1016\/j.jacbts.2025.04.015","journal-title":"JACC: Basic to Translational Science"},{"key":"10204_CR193","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/oxfordjournals.jbchem.a129974","volume":"72","author":"T Saito","year":"1972","unstructured":"Saito, T., & Tomita, K. (1972). Malic enzyme activity in heart. The Journal of Biochemistry,72, 807\u2013815. https:\/\/doi.org\/10.1093\/oxfordjournals.jbchem.a129974","journal-title":"The Journal of Biochemistry"},{"key":"10204_CR194","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0006-3002(58)90177-X","volume":"29","author":"SJ Wakil","year":"1958","unstructured":"Wakil, S. J., Titchener, E. B., & Gibson, D. M. (1958). Evidence for the participation of biotin in the enzymic synthesis of fatty acids. Biochimica et Biophysica Acta,29, 225\u2013226. https:\/\/doi.org\/10.1016\/0006-3002(58)90177-X","journal-title":"Biochimica et Biophysica Acta"},{"key":"10204_CR195","doi-asserted-by":"publisher","first-page":"6465","DOI":"10.1021\/ja01556a086","volume":"80","author":"SJ Wakil","year":"1958","unstructured":"Wakil, S. J. (1958). A malonic acid derivative as an intermediate in fatty acid synthesis. Journal of the American Chemical Society,80, 6465\u20136465. https:\/\/doi.org\/10.1021\/ja01556a086","journal-title":"Journal of the American Chemical Society"},{"key":"10204_CR196","doi-asserted-by":"publisher","first-page":"25836","DOI":"10.1016\/S0021-9258(19)74465-2","volume":"268","author":"M Saddik","year":"1993","unstructured":"Saddik, M., Gamble, J., Witters, L. A., & Lopaschuk, G. D. (1993). Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. Journal of Biological Chemistry,268, 25836\u201325845. https:\/\/doi.org\/10.1016\/S0021-9258(19)74465-2","journal-title":"Journal of Biological Chemistry"},{"key":"10204_CR197","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1146\/annurev.bi.52.070183.002541","volume":"52","author":"SJ Wakil","year":"1983","unstructured":"Wakil, S. J., Stoops, J. K., & Joshi, V. C. (1983). Fatty acid synthesis and its regulation. Annual Review of Biochemistry,52, 537\u2013579. https:\/\/doi.org\/10.1146\/annurev.bi.52.070183.002541","journal-title":"Annual Review of Biochemistry"},{"key":"10204_CR198","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0022-2828(73)90025-4","volume":"5","author":"FE Hull","year":"1973","unstructured":"Hull, F. E., Cheney, H., & Baker, L. (1973). Fatty acid synthesis and Krebs\u2019 cycle activity in heart mitochondria. Journal of Molecular and Cellular Cardiology,5, 319\u2013339. https:\/\/doi.org\/10.1016\/0022-2828(73)90025-4","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10204_CR199","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/s41422-019-0208-x","volume":"29","author":"T Hou","year":"2019","unstructured":"Hou, T., Zhang, R., Jian, C., Ding, W., Wang, Y., Ling, S., Ma, Q., Hu, X., Cheng, H., & Wang, X. (2019). NDUFAB1 confers cardio-protection by enhancing mitochondrial bioenergetics through coordination of respiratory complex and supercomplex assembly. Cell Research,29, 754\u2013766. https:\/\/doi.org\/10.1038\/s41422-019-0208-x","journal-title":"Cell Research"},{"key":"10204_CR200","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1146\/annurev.biochem.74.082803.133524","volume":"74","author":"SW White","year":"2005","unstructured":"White, S. W., Zheng, J., Zhang, Y.-M., & Rock, C. O. (2005). The structural biology of type II fatty acid biosynthesis. Annual Review of Biochemistry,74, 791\u2013831. https:\/\/doi.org\/10.1146\/annurev.biochem.74.082803.133524","journal-title":"Annual Review of Biochemistry"},{"key":"10204_CR201","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/sj.tpj.6500323","volume":"5","author":"J Fern\u00f8","year":"2005","unstructured":"Fern\u00f8, J., Raeder, M. B., Vik-Mo, A. O., Skrede, S., Glambek, M., Tronstad, K. J., Breilid, H., L\u00f8vlie, R., Berge, R. K., Stansberg, C., & Steen, V. M. (2005). Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: A novel mechanism of action? The Pharmacogenomics Journal,5, 298\u2013304. https:\/\/doi.org\/10.1038\/sj.tpj.6500323","journal-title":"The Pharmacogenomics Journal"},{"key":"10204_CR202","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.neuropharm.2011.08.048","volume":"62","author":"E Lauressergues","year":"2012","unstructured":"Lauressergues, E., Bert, E., Duriez, P., Hum, D., Majd, Z., Staels, B., & Cussac, D. (2012). Does endoplasmic reticulum stress participate in APD-induced hepatic metabolic dysregulation? Neuropharmacology,62, 784\u2013796. https:\/\/doi.org\/10.1016\/j.neuropharm.2011.08.048","journal-title":"Neuropharmacology"},{"key":"10204_CR203","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/mol.113.089755","volume":"85","author":"LB Avery","year":"2014","unstructured":"Avery, L. B., & Bumpus, N. N. (2014). Valproic acid is a novel activator of AMP-activated protein kinase and decreases liver mass, hepatic fat accumulation, and serum glucose in obese mice. Molecular Pharmacology,85, 1\u201310. https:\/\/doi.org\/10.1124\/mol.113.089755","journal-title":"Molecular Pharmacology"},{"key":"10204_CR204","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1042\/BJ20131476","volume":"459","author":"M Yuyama","year":"2014","unstructured":"Yuyama, M., & Fujimori, K. (2014). Suppression of adipogenesis by valproic acid through repression of USF1-activated fatty acid synthesis in adipocytes. Biochemical Journal,459, 489\u2013503. https:\/\/doi.org\/10.1042\/BJ20131476","journal-title":"Biochemical Journal"},{"key":"10204_CR205","doi-asserted-by":"publisher","first-page":"3550","DOI":"10.1021\/ja01595a088","volume":"78","author":"SB Weiss","year":"1956","unstructured":"Weiss, S. B., & Kennedy, E. P. (1956). The enzymatic synthesis of triglycerides. Journal of the American Chemical Society,78, 3550\u20133550. https:\/\/doi.org\/10.1021\/ja01595a088","journal-title":"Journal of the American Chemical Society"},{"key":"10204_CR206","doi-asserted-by":"publisher","unstructured":"Heier, C. and Haemmerle, G. (2016). Fat in the heart: The enzymatic machinery regulating cardiac triacylglycerol metabolism. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1861: 1500\u20131512. https:\/\/doi.org\/10.1016\/j.bbalip.2016.02.014","DOI":"10.1016\/j.bbalip.2016.02.014"},{"key":"10204_CR207","doi-asserted-by":"publisher","first-page":"3825","DOI":"10.1016\/S0021-9258(19)50600-7","volume":"267","author":"M Saddik","year":"1992","unstructured":"Saddik, M., & Lopaschuk, G. D. (1992). Myocardial triglyceride turnover during reperfusion of isolated rat hearts subjected to a transient period of global ischemia. Journal of Biological Chemistry,267, 3825\u20133831. https:\/\/doi.org\/10.1016\/S0021-9258(19)50600-7","journal-title":"Journal of Biological Chemistry"},{"key":"10204_CR208","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1161\/CIRCRESAHA.110.221713","volume":"107","author":"NH Banke","year":"2010","unstructured":"Banke, N. H., Wende, A. R., Leone, T. C., O\u2019Donnell, J. M., Abel, E. D., Kelly, D. P., & Lewandowski, E. D. (2010). Preferential oxidation of triacylglyceride-derived fatty acids in heart is augmented by the nuclear receptor PPAR\u03b1. Circulation Research,107, 233\u2013241. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.221713","journal-title":"Circulation Research"},{"key":"10204_CR209","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1113\/JP284272","volume":"601","author":"AP Oneglia","year":"2023","unstructured":"Oneglia, A. P., Szczepaniak, L. S., Jaffery, M. F., Cipher, D. J., McDonald, J. G., Haykowsky, M. J., Moreau, K. L., Clegg, D. J., Zaha, V., & Nelson, M. D. (2023). Myocardial steatosis impairs left ventricular diastolic\u2013systolic coupling in healthy humans. The Journal of Physiology,601, 1371\u20131382. https:\/\/doi.org\/10.1113\/JP284272","journal-title":"The Journal of Physiology"},{"key":"10204_CR210","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1152\/jappl.1972.32.6.847","volume":"32","author":"L Kaijser","year":"1972","unstructured":"Kaijser, L., Lassers, B. W., Wahlqvist, M. L., & Carlson, L. A. (1972). Myocardial lipid and carbohydrate metabolism in fasting men during prolonged exercise. Journal of Applied Physiology,32, 847\u2013858. https:\/\/doi.org\/10.1152\/jappl.1972.32.6.847","journal-title":"Journal of Applied Physiology"},{"key":"10204_CR211","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1210\/jc.2007-2015","volume":"93","author":"S Hammer","year":"2008","unstructured":"Hammer, S., van der Meer, R. W., Lamb, H. J., Sch\u00e4r, M., de Roos, A., Smit, J. W. A., & Romijn, J. A. (2008). Progressive caloric restriction induces dose-dependent changes in myocardial triglyceride content and diastolic function in healthy men. The Journal of Clinical Endocrinology & Metabolism,93, 497\u2013503. https:\/\/doi.org\/10.1210\/jc.2007-2015","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"10204_CR212","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1152\/ajplegacy.1966.210.2.385","volume":"210","author":"RA Kreisberg","year":"1966","unstructured":"Kreisberg, R. A. (1966). Effect of epinephrine on myocardial triglyceride and free fatty acid utilization. American Journal of Physiology-Legacy Content,210, 385\u2013389. https:\/\/doi.org\/10.1152\/ajplegacy.1966.210.2.385","journal-title":"American Journal of Physiology-Legacy Content"},{"key":"10204_CR213","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1042\/bj3280913","volume":"328","author":"MSE Swanton","year":"1997","unstructured":"Swanton, M. S. E., & Saggerson, E. D. (1997). Effects of adrenaline on triacylglycerol synthesis and turnover in ventricular myocytes from adult rats. Biochemical Journal,328, 913\u2013922. https:\/\/doi.org\/10.1042\/bj3280913","journal-title":"Biochemical Journal"},{"key":"10204_CR214","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.jacc.2008.07.062","volume":"52","author":"LJ Rijzewijk","year":"2008","unstructured":"Rijzewijk, L. J., van der Meer, R. W., Smit, J. W. A., Diamant, M., Bax, J. J., Hammer, S., Romijn, J. A., de Roos, A., & Lamb, H. J. (2008). Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. Journal of the American College of Cardiology,52, 1793\u20131799. https:\/\/doi.org\/10.1016\/j.jacc.2008.07.062","journal-title":"Journal of the American College of Cardiology"},{"key":"10204_CR215","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2025.159611","volume":"1870","author":"I Chavarr\u00eda-Cubel","year":"2025","unstructured":"Chavarr\u00eda-Cubel, I., Molina, Y. L., Babiy, B., Lerma, M., Mart\u00ednez-Botas, J., de la Pe\u00f1a, G., Vallejo, M. T., Villanueva-Blanco, T., G\u00f3mez-Coronado, D., Alcazar, A., Lasunci\u00f3n, M. A., Pastor, \u00d3., & Busto, R. (2025). The synthetic TRPML1 agonist ML-SA1 mitigates intracellular lipid accumulation induced by antipsychotics in vitro by stimulating release of extracellular microvesicles. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids,1870, Article 159611. https:\/\/doi.org\/10.1016\/j.bbalip.2025.159611","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"},{"key":"10204_CR216","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11323-9","volume":"7","author":"C-C Chen","year":"2017","unstructured":"Chen, C.-C., Hsu, L.-W., Huang, K.-T., Goto, S., Chen, C.-L., & Nakano, T. (2017). Overexpression of Insig-2 inhibits atypical antipsychotic-induced adipogenic differentiation and lipid biosynthesis in adipose-derived stem cells. Scientific Reports,7, Article 10901. https:\/\/doi.org\/10.1038\/s41598-017-11323-9","journal-title":"Scientific Reports"},{"key":"10204_CR217","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/sj.npp.1301142","volume":"32","author":"HS Vestri","year":"2007","unstructured":"Vestri, H. S., Maianu, L., Moellering, D. R., & Garvey, W. T. (2007). Atypical antipsychotic drugs directly impair insulin action in adipocytes: Effects on glucose transport, lipogenesis, and antilipolysis. Neuropsychopharmacology,32, 765\u2013772. https:\/\/doi.org\/10.1038\/sj.npp.1301142","journal-title":"Neuropsychopharmacology"},{"key":"10204_CR218","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.taap.2007.09.014","volume":"226","author":"M-H Lee","year":"2008","unstructured":"Lee, M.-H., Kim, M., Lee, B.-H., Kim, J.-H., Kang, K.-S., Kim, H.-L., Yoon, B.-I., Chung, H., Kong, G., & Lee, M.-O. (2008). Subchronic effects of valproic acid on gene expression profiles for lipid metabolism in mouse liver. Toxicology and Applied Pharmacology,226, 271\u2013284. https:\/\/doi.org\/10.1016\/j.taap.2007.09.014","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10204_CR219","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00204-015-1483-z","volume":"90","author":"RM Rodrigues","year":"2016","unstructured":"Rodrigues, R. M., Branson, S., De Boe, V., Sachinidis, A., Rogiers, V., De Kock, J., & Vanhaecke, T. (2016). In vitro assessment of drug-induced liver steatosis based on human dermal stem cell-derived hepatic cells. Archives of Toxicology,90, 677\u2013689. https:\/\/doi.org\/10.1007\/s00204-015-1483-z","journal-title":"Archives of Toxicology"},{"key":"10204_CR220","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1055\/s-2007-973710","volume":"28","author":"B Melegh","year":"1997","unstructured":"Melegh, B., & Trombit\u00e1s, K. (1997). Valproate treatment induces lipid globule accumulation with ultrastructural abnormalities of mitochondria in skeletal muscle. Neuropediatrics,28, 257\u2013261. https:\/\/doi.org\/10.1055\/s-2007-973710","journal-title":"Neuropediatrics"},{"key":"10204_CR221","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0960-8966(91)90097-C","volume":"1","author":"A Papadimitriou","year":"1991","unstructured":"Papadimitriou, A., & Servidei, S. (1991). Late onset lipid storage myopathy due to multiple acyl CoA dehydrogenase deficiency triggered by valproate. Neuromuscular Disorders,1, 247\u2013252. https:\/\/doi.org\/10.1016\/0960-8966(91)90097-C","journal-title":"Neuromuscular Disorders"},{"key":"10204_CR222","doi-asserted-by":"publisher","unstructured":"D''Souza, K., Nzirorera, C. and Kienesberger, P.C. (2016). Lipid metabolism and signaling in cardiac lipotoxicity. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1861: 1513\u20131524. https:\/\/doi.org\/10.1016\/j.bbalip.2016.02.016","DOI":"10.1016\/j.bbalip.2016.02.016"},{"key":"10204_CR223","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1113\/jphysiol.2008.168286","volume":"587","author":"BC Bergman","year":"2009","unstructured":"Bergman, B. C., Tsvetkova, T., Lowes, B., & Wolfel, E. E. (2009). Myocardial glucose and lactate metabolism during rest and atrial pacing in humans. Journal of Physiology,587, 2087\u20132099. https:\/\/doi.org\/10.1113\/jphysiol.2008.168286","journal-title":"Journal of Physiology"},{"key":"10204_CR224","doi-asserted-by":"publisher","first-page":"E309","DOI":"10.1152\/ajpendo.1989.257.3.E309","volume":"257","author":"P Camici","year":"1989","unstructured":"Camici, P., Marraccini, P., Marzilli, M., Lorenzoni, R., Buzzigoli, G., Puntoni, R., Boni, C., Bellina, C. R., Klassen, G. A., & L\u2019Abbate, A. (1989). Coronary hemodynamics and myocardial metabolism during and after pacing stress in normal humans. American Journal of Physiology-Endocrinology and Metabolism,257, E309\u2013E317. https:\/\/doi.org\/10.1152\/ajpendo.1989.257.3.E309","journal-title":"American Journal of Physiology-Endocrinology and Metabolism"},{"key":"10204_CR225","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1172\/JCI113822","volume":"82","author":"EW Gertz","year":"1988","unstructured":"Gertz, E. W., Wisneski, J. A., Stanley, W. C., & Neese, R. A. (1988). Myocardial substrate utilization during exercise in humans. Dual carbon-labeled carbohydrate isotope experiments. Journal of Clinical Investigation,82, 2017\u20132025. https:\/\/doi.org\/10.1172\/JCI113822","journal-title":"Journal of Clinical Investigation"},{"key":"10204_CR226","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/S0140-6736(71)92624-9","volume":"298","author":"BW Lassers","year":"1971","unstructured":"Lassers, B. W., Kaijser, L., Wahlqvist, M. L., & Carlson, L. A. (1971). Relationship in man between plasma free fatty acids and myocardial metabolism of carbohydrate substrates. The Lancet,298, 448\u2013450. https:\/\/doi.org\/10.1016\/S0140-6736(71)92624-9","journal-title":"The Lancet"},{"key":"10204_CR227","doi-asserted-by":"publisher","unstructured":"Gormsen, L.C., Svart, M., Thomsen, H.H., S\u00f8ndergaard, E., Vendelbo, M.H., Christensen, N., Tolbod, L.P., Harms, H.J., Nielsen, R., Wiggers, H., Jessen, N., Hansen, J., B\u00f8tker, H.E. and M\u00f8ller, N. (2017). Ketone body infusion with 3\u2010hydroxybutyrate reduces myocardial glucose uptake and increases blood flow in humans: A positron emission tomography study. Journal of the American Heart Association 6: Article e005066. https:\/\/doi.org\/10.1161\/JAHA.116.005066","DOI":"10.1161\/JAHA.116.005066"},{"key":"10204_CR228","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1172\/JCI112174","volume":"76","author":"JA Wisneski","year":"1985","unstructured":"Wisneski, J. A., Gertz, E. W., Neese, R. A., Gruenke, L. D., Morris, D. L., & Craig, J. C. (1985). Metabolic fate of extracted glucose in normal human myocardium. The Journal of Clinical Investigation,76, 1819\u20131827. https:\/\/doi.org\/10.1172\/JCI112174","journal-title":"The Journal of Clinical Investigation"},{"key":"10204_CR229","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1172\/JCI114616","volume":"85","author":"JA Wisneski","year":"1990","unstructured":"Wisneski, J. A., Stanley, W. C., Neese, R. A., & Gertz, E. W. (1990). Effects of acute hyperglycemia on myocardial glycolytic activity in humans. The Journal of Clinical Investigation,85, 1648\u20131656. https:\/\/doi.org\/10.1172\/JCI114616","journal-title":"The Journal of Clinical Investigation"},{"key":"10204_CR230","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/0003-9861(84)90554-X","volume":"232","author":"E Aubert-Foucher","year":"1984","unstructured":"Aubert-Foucher, E., Font, B., & Gautheron, D. C. (1984). Rabbit heart mitochondrial hexokinase: Solubilization and general properties. Archives of Biochemistry and Biophysics,232, 391\u2013399. https:\/\/doi.org\/10.1016\/0003-9861(84)90554-X","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10204_CR231","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a040535","volume":"13","author":"NS Chandel","year":"2021","unstructured":"Chandel, N. S. (2021). Glycolysis. Cold Spring Harbor Perspectives in Biology,13, Article a040535. https:\/\/doi.org\/10.1101\/cshperspect.a040535","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"10204_CR232","doi-asserted-by":"publisher","first-page":"25502","DOI":"10.1016\/S0021-9258(18)47278-X","volume":"269","author":"Y Kashiwaya","year":"1994","unstructured":"Kashiwaya, Y., Sato, K., Tsuchiya, N., Thomas, S., Fell, D. A., Veech, R. L., & Passonneau, J. V. (1994). Control of glucose utilization in working perfused rat heart. Journal of Biological Chemistry,269, 25502\u201325514. https:\/\/doi.org\/10.1016\/S0021-9258(18)47278-X","journal-title":"Journal of Biological Chemistry"},{"key":"10204_CR233","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0026-895X(25)14804-9","volume":"2","author":"SE Mayer","year":"1966","unstructured":"Mayer, S. E., Mayfield, A. C., & Haas, J. A. (1966). Heart muscle hexokinase: Subcellular distribution and inhibition by glucose 6-phosphate. Molecular Pharmacology,2, 393\u2013405. https:\/\/doi.org\/10.1016\/S0026-895X(25)14804-9","journal-title":"Molecular Pharmacology"},{"key":"10204_CR234","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1016\/0024-3205(67)90071-9","volume":"6","author":"G Weber","year":"1967","unstructured":"Weber, G., Lea, M. A., & Stamm, N. B. (1967). Inhibition of pyruvate kinase and glucokinase by acetyl CoA and inhibition of glucokinase by phosphoenolpyruvate. Life Sciences,6, 2441\u20132452. https:\/\/doi.org\/10.1016\/0024-3205(67)90071-9","journal-title":"Life Sciences"},{"key":"10204_CR235","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1042\/bj1000420","volume":"100","author":"RM Denton","year":"1966","unstructured":"Denton, R. M., & Randle, P. J. (1966). Citrate and the regulation of adipose-tissue phosphofructokinase. Biochemical Journal,100, 420\u2013423. https:\/\/doi.org\/10.1042\/bj1000420","journal-title":"Biochemical Journal"},{"key":"10204_CR236","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1432-1033.1970.tb00897.x","volume":"13","author":"P Llorente","year":"1970","unstructured":"Llorente, P., Marco, R., & Sols, A. (1970). Regulation of liver pyruvate kinase and the phosphoenolpyruvate crossroads. European Journal of Biochemistry,13, 45\u201354. https:\/\/doi.org\/10.1111\/j.1432-1033.1970.tb00897.x","journal-title":"European Journal of Biochemistry"},{"key":"10204_CR237","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1177\/1535370217743919","volume":"243","author":"RT Mallet","year":"2017","unstructured":"Mallet, R. T., Olivencia-Yurvati, A. H., & B\u00fcnger, R. (2017). Pyruvate enhancement of cardiac performance: Cellular mechanisms and clinical application. Experimental Biology and Medicine,243, 198\u2013210. https:\/\/doi.org\/10.1177\/1535370217743919","journal-title":"Experimental Biology and Medicine"},{"key":"10204_CR238","first-page":"90","volume":"45","author":"R Meierhenrich","year":"1996","unstructured":"Meierhenrich, R., Jedicke, H., Voigt, A., & Lange, H. (1996). The effect of erythropoietin on lactate, pyruvate and excess lactate under physical exercise in dialysis patients. Clinical Nephrology,45, 90\u201397.","journal-title":"Clinical Nephrology"},{"key":"10204_CR239","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/0002-9343(53)90082-5","volume":"15","author":"RJ Bing","year":"1953","unstructured":"Bing, R. J., Siegel, A., Vitale, A., Balboni, F., Sparks, E., Taeschler, M., Klapper, M., & Edwards, S. (1953). Metabolic studies on the human heart in vivo: I. Studies on carbohydrate metabolism of the human heart. The American Journal of Medicine,15, 284\u2013296. https:\/\/doi.org\/10.1016\/0002-9343(53)90082-5","journal-title":"The American Journal of Medicine"},{"key":"10204_CR240","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1113\/JP278930","volume":"599","author":"B Glancy","year":"2021","unstructured":"Glancy, B., Kane, D. A., Kavazis, A. N., Goodwin, M. L., Willis, W. T., & Gladden, L. B. (2021). Mitochondrial lactate metabolism: History and implications for exercise and disease. Journal of Physiology,599, 863\u2013888. https:\/\/doi.org\/10.1113\/JP278930","journal-title":"Journal of Physiology"},{"key":"10204_CR241","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1365-2362.1973.tb00330.x","volume":"3","author":"ML Wahlqvist","year":"1973","unstructured":"Wahlqvist, M. L., Kaijser, L., Lassers, B. W., L\u00f6w, H., & Carlson, L. A. (1973). The role of fatty acid and of hormones in the determination of myocardial carbohydrate metabolism in healthy fasting men. European Journal of Clinical Investigation,3, 57\u201365. https:\/\/doi.org\/10.1111\/j.1365-2362.1973.tb00330.x","journal-title":"European Journal of Clinical Investigation"},{"key":"10204_CR242","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1080\/00365516109137305","volume":"13","author":"A Carlsten","year":"1961","unstructured":"Carlsten, A., Hallgren, B., Jagenburg, R., Svanborg, A., Werk\u00f6, L., Jagenburg, M., Larsson, S., & Myr\u00e9n, I. (1961). Myorcardial metabolism of glucose, lactic acid, amino acids and fatty acids in healthy human individuals at rest and at different work loads. Scandinavian Journal of Clinical and Laboratory Investigation,13, 418\u2013428. https:\/\/doi.org\/10.1080\/00365516109137305","journal-title":"Scandinavian Journal of Clinical and Laboratory Investigation"},{"key":"10204_CR243","doi-asserted-by":"publisher","first-page":"E606","DOI":"10.1152\/ajpendo.1990.258.4.E606","volume":"258","author":"A Avogaro","year":"1990","unstructured":"Avogaro, A., Nosadini, R., Doria, A., Fioretto, P., Velussi, M., Vigorito, C., Sacca, L., Toffolo, G., Cobelli, C., & Trevisan, R. (1990). Myocardial metabolism in insulin-deficient diabetic humans without coronary artery disease. American Journal of Physiology-Endocrinology and Metabolism,258, E606\u2013E618. https:\/\/doi.org\/10.1152\/ajpendo.1990.258.4.E606","journal-title":"American Journal of Physiology-Endocrinology and Metabolism"},{"key":"10204_CR244","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psyneuen.2016.07.209","volume":"73","author":"Y-C Huang","year":"2016","unstructured":"Huang, Y.-C., Lin, P.-Y., Lee, Y., Wu, C.-C., Hsu, S.-T., Hung, C.-F., Chen, C.-C., Chong, M.-Y., Lin, C.-H., & Wang, L.-J. (2016). \u03b2-hydroxybutyrate, pyruvate and metabolic profiles in patients with schizophrenia: A case control study. Psychoneuroendocrinology,73, 1\u20138. https:\/\/doi.org\/10.1016\/j.psyneuen.2016.07.209","journal-title":"Psychoneuroendocrinology"},{"key":"10204_CR245","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3109\/00498258509047438","volume":"15","author":"V Rogiers","year":"1985","unstructured":"Rogiers, V., Vandenberghe, Y., & Vercruysse, A. (1985). Inhibition of gluconeogenesis by sodium valproate and its metabolites in isolated rat hepatocytes. Xenobiotica,15, 759\u2013765. https:\/\/doi.org\/10.3109\/00498258509047438","journal-title":"Xenobiotica"},{"key":"10204_CR246","first-page":"45","volume":"2","author":"DM Turnbull","year":"1985","unstructured":"Turnbull, D. M., Bone, A. J., Tames, F. J., Wilson, L., Baird, J. D., & Sherratt, H. S. (1985). The effect of valproate on blood metabolite concentrations in spontaneously diabetic, ketoacidotic, BB\/E Wistar rats. Diabetes Research,2, 45\u201348.","journal-title":"Diabetes Research"},{"key":"10204_CR247","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/jnnp.49.4.405","volume":"49","author":"DM Turnbull","year":"1986","unstructured":"Turnbull, D. M., Dick, D. J., Wilson, L., Sherratt, H. S., & Alberti, K. G. (1986). Valproate causes metabolic disturbance in normal man. Journal of Neurology, Neurosurgery & Psychiatry,49, 405. https:\/\/doi.org\/10.1136\/jnnp.49.4.405","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"10204_CR248","doi-asserted-by":"publisher","first-page":"E130","DOI":"10.1152\/ajpendo.00158.2021","volume":"321","author":"ED Abel","year":"2021","unstructured":"Abel, E. D. (2021). Insulin signaling in the heart. American Journal of Physiology - Endocrinology and Metabolism,321, E130\u2013E145. https:\/\/doi.org\/10.1152\/ajpendo.00158.2021","journal-title":"American Journal of Physiology - Endocrinology and Metabolism"},{"key":"10204_CR249","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.yjmcc.2009.08.028","volume":"47","author":"H Ikeda","year":"2009","unstructured":"Ikeda, H., Shiojima, I., Ozasa, Y., Yoshida, M., Holzenberger, M., Kahn, C. R., Walsh, K., Igarashi, T., Abel, E. D., & Komuro, I. (2009). Interaction of myocardial insulin receptor and IGF receptor signaling in exercise-induced cardiac hypertrophy. Journal of Molecular and Cellular Cardiology,47, 664\u2013675. https:\/\/doi.org\/10.1016\/j.yjmcc.2009.08.028","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10204_CR250","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/BF00395557","volume":"31","author":"D Zaninetti","year":"1988","unstructured":"Zaninetti, D., Greco-Perotto, R., & Jeanrenaud, B. (1988). Heart glucose transport and transporters in rat heart: Regulation by insulin, workload and glucose. Diabetologia,31, 108\u2013113. https:\/\/doi.org\/10.1007\/BF00395557","journal-title":"Diabetologia"},{"key":"10204_CR251","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1006\/jmcc.1999.0965","volume":"31","author":"S Egert","year":"1999","unstructured":"Egert, S., Nguyen, N., & Schwaiger, M. (1999). Myocardial glucose transporter GLUT1: Translocation induced by insulin and ischemia. Journal of Molecular and Cellular Cardiology,31, 1337\u20131344. https:\/\/doi.org\/10.1006\/jmcc.1999.0965","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10204_CR252","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2741\/1216","volume":"9","author":"ED Abel","year":"2004","unstructured":"Abel, E. D. (2004). Glucose transport in the heart. Frontiers in Bioscience,9, 201\u2013215. https:\/\/doi.org\/10.2741\/1216","journal-title":"Frontiers in Bioscience"},{"key":"10204_CR253","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1172\/JCI13946","volume":"109","author":"DD Belke","year":"2002","unstructured":"Belke, D. D., Betuing, S., Tuttle, M. J., Graveleau, C., Young, M. E., Pham, M., Zhang, D., Cooksey, R. C., McClain, D. A., Litwin, S. E., Taegtmeyer, H., Severson, D., Kahn, C. R., & Abel, E. D. (2002). Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. The Journal of Clinical Investigation,109, 629\u2013639. https:\/\/doi.org\/10.1172\/JCI13946","journal-title":"The Journal of Clinical Investigation"},{"key":"10204_CR254","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/0014-5793(84)81223-5","volume":"176","author":"MH Rider","year":"1984","unstructured":"Rider, M. H., & Hue, L. (1984). Activation of rat heart phosphofructokinase-2 by insulin in vivo. FEBS Letters,176, 484\u2013488. https:\/\/doi.org\/10.1016\/0014-5793(84)81223-5","journal-title":"FEBS Letters"},{"key":"10204_CR255","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1042\/BJ20101089","volume":"431","author":"V Mouton","year":"2010","unstructured":"Mouton, V., Toussaint, L., Vertommen, D., Gueuning, M.-A., Maisin, L., Havaux, X., Sanchez-Canedo, C., Bertrand, L., Dequiedt, F., Hemmings, B. A., Hue, L., & Rider, M. H. (2010). Heart 6-phosphofructo-2-kinase activation by insulin requires PKB (protein kinase B), but not SGK3 (serum- and glucocorticoid-induced protein kinase 3). Biochemical Journal,431, 267\u2013275. https:\/\/doi.org\/10.1042\/BJ20101089","journal-title":"Biochemical Journal"},{"key":"10204_CR256","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-020-01177-3","volume":"19","author":"QG Karwi","year":"2020","unstructured":"Karwi, Q. G., Wagg, C. S., Altamimi, T. R., Uddin, G. M., Ho, K. L., Darwesh, A. M., Seubert, J. M., & Lopaschuk, G. D. (2020). Insulin directly stimulates mitochondrial glucose oxidation in the heart. Cardiovascular Diabetology,19, Article 207. https:\/\/doi.org\/10.1186\/s12933-020-01177-3","journal-title":"Cardiovascular Diabetology"},{"key":"10204_CR257","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1677\/JOE-09-0046","volume":"201","author":"JJFP Luiken","year":"2009","unstructured":"Luiken, J. J. F. P., Ouwens, D. M., Habets, D. D. J., van der Zon, G. C. M., Coumans, W. A., Schwenk, R. W., Bonen, A., & Glatz, J. F. C. (2009). Permissive action of protein kinase C-\u03b6 in insulin-induced CD36- and GLUT4 translocation in cardiac myocytes. Journal of Endocrinology,201, 199\u2013209. https:\/\/doi.org\/10.1677\/JOE-09-0046","journal-title":"Journal of Endocrinology"},{"key":"10204_CR258","doi-asserted-by":"publisher","first-page":"E308","DOI":"10.1152\/ajpendo.1993.264.2.E308","volume":"264","author":"E Ferrannini","year":"1993","unstructured":"Ferrannini, E., Santoro, D., Bonadonna, R., Natali, A., Parodi, O., & Camici, P. G. (1993). Metabolic and hemodynamic effects of insulin on human hearts. American Journal of Physiology-Endocrinology and Metabolism,264, E308\u2013E315. https:\/\/doi.org\/10.1152\/ajpendo.1993.264.2.E308","journal-title":"American Journal of Physiology-Endocrinology and Metabolism"},{"key":"10204_CR259","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2337\/diab.44.5.537","volume":"44","author":"LD Monti","year":"1995","unstructured":"Monti, L. D., Lucignani, G., Landoni, C., Moresco, R. M., Piatti, P., Stefani, I., Pozza, G., & Fazio, F. (1995). Myocardial glucose uptake evaluated by positron emission tomography and fluorodeoxyglucose during hyperglycemic clamp in IDDM patients: Role of free fatty acid and insulin levels. Diabetes,44, 537\u2013542. https:\/\/doi.org\/10.2337\/diab.44.5.537","journal-title":"Diabetes"},{"key":"10204_CR260","doi-asserted-by":"publisher","first-page":"39422","DOI":"10.1074\/jbc.M305371200","volume":"278","author":"S Kovacic","year":"2003","unstructured":"Kovacic, S., Soltys, C.-L.M., Barr, A. J., Shiojima, I., Walsh, K., & Dyck, J. R. B. (2003). Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart. Journal of Biological Chemistry,278, 39422\u201339427. https:\/\/doi.org\/10.1074\/jbc.M305371200","journal-title":"Journal of Biological Chemistry"},{"key":"10204_CR261","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/S0026-0495(97)90229-8","volume":"46","author":"J Gamble","year":"1997","unstructured":"Gamble, J., & Lopaschuk, G. D. (1997). Insulin inhibition of 5\u2032 adenosine monophosphate\u2014activated protein kinase in the heart results in activation of acetyl coenzyme A carboxylase and inhibition of fatty acid oxidation. Metabolism,46, 1270\u20131274. https:\/\/doi.org\/10.1016\/S0026-0495(97)90229-8","journal-title":"Metabolism"},{"key":"10204_CR262","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050077","volume":"7","author":"D Jankovic","year":"2012","unstructured":"Jankovic, D., Winhofer, Y., Promintzer-Schifferl, M., Wohlschl\u00e4ger-Krenn, E., Anderwald, C. H., Wolf, P., Scherer, T., Reiter, G., Trattnig, S., Luger, A., Krebs, M., & Krssak, M. (2012). Effects of insulin therapy on myocardial lipid content and cardiac geometry in patients with type-2 diabetes mellitus. PLoS ONE,7, Article e50077. https:\/\/doi.org\/10.1371\/journal.pone.0050077","journal-title":"PLoS ONE"},{"key":"10204_CR263","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/JCP.0000000000001192","volume":"40","author":"S Grover","year":"2020","unstructured":"Grover, S., Verma, M., & Chakrabarti, S. (2020). Safety of use of clozapine in patients with schizophrenia with comorbid diabetes mellitus. Journal of Clinical Psychopharmacology,40, 276\u2013282. https:\/\/doi.org\/10.1097\/JCP.0000000000001192","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10204_CR264","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1176\/appi.ajp.161.9.1709","volume":"161","author":"DL Leslie","year":"2004","unstructured":"Leslie, D. L., & Rosenheck, R. A. (2004). Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications. American Journal of Psychiatry,161, 1709\u20131711. https:\/\/doi.org\/10.1176\/appi.ajp.161.9.1709","journal-title":"American Journal of Psychiatry"},{"key":"10204_CR265","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.727371","volume":"12","author":"T Cao","year":"2021","unstructured":"Cao, T., Chen, Q., Zhang, B., Wu, X., Zeng, C., Zhang, S., & Cai, H. (2021). Clozapine induced disturbances in hepatic glucose metabolism: The potential role of PGRMC1 signaling. Frontiers in Endocrinology,12, Article Article 727371. https:\/\/doi.org\/10.3389\/fendo.2021.727371","journal-title":"Frontiers in Endocrinology"},{"key":"10204_CR266","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0165-1","volume":"6","author":"KK Dhatariya","year":"2020","unstructured":"Dhatariya, K. K., Glaser, N. S., Codner, E., & Umpierrez, G. E. (2020). Diabetic ketoacidosis. Nature Reviews Disease Primers,6, Article 40. https:\/\/doi.org\/10.1038\/s41572-020-0165-1","journal-title":"Nature Reviews Disease Primers"},{"key":"10204_CR267","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1136\/pgmj.74.874.493","volume":"74","author":"D Ai","year":"1998","unstructured":"Ai, D., Roper, T. A., & Riley, J. A. (1998). Diabetic ketoacidosis and clozapine. Postgraduate Medical Journal,74, 493\u2013494. https:\/\/doi.org\/10.1136\/pgmj.74.874.493","journal-title":"Postgraduate Medical Journal"},{"key":"10204_CR268","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1345\/aph.10424","volume":"35","author":"AM Avram","year":"2001","unstructured":"Avram, A. M., Patel, V., Taylor, H. C., Kirwan, J. P., & Kalhan, S. (2001). Euglycemic clamp study in clozapine-induced diabetic ketoacidosis. Annals of Pharmacotherapy,35, 1381\u20131387. https:\/\/doi.org\/10.1345\/aph.10424","journal-title":"Annals of Pharmacotherapy"},{"key":"10204_CR269","doi-asserted-by":"publisher","first-page":"176","DOI":"10.2337\/diacare.22.1.176a","volume":"22","author":"A Colli","year":"1999","unstructured":"Colli, A., Cocciolo, M., Francobandiera, F., Rogantin, F., & Cattalini, N. (1999). Diabetic ketoacidosis associated with clozapine treatment. Diabetes Care,22, 176\u2013177. https:\/\/doi.org\/10.2337\/diacare.22.1.176a","journal-title":"Diabetes Care"},{"key":"10204_CR270","doi-asserted-by":"publisher","first-page":"533","DOI":"10.4088\/jcp.v68n0407","volume":"68","author":"DC Henderson","year":"2007","unstructured":"Henderson, D. C., Cagliero, E., Copeland, P. M., Louie, P. M., Borba, C. P., Fan, X., Freudenreich, O., & Goff, D. C. (2007). Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics. Journal of Clinical Psychiatry,68, 533\u2013541. https:\/\/doi.org\/10.4088\/jcp.v68n0407","journal-title":"Journal of Clinical Psychiatry"},{"key":"10204_CR271","doi-asserted-by":"publisher","unstructured":"Hepburn, K. and Brzozowska, M.M. (2016). Diabetic ketoacidosis and severe hypertriglyceridaemia as a consequence of an atypical antipsychotic agent. BMJ Case Reports CP2016: bcr2016215413. https:\/\/doi.org\/10.1136\/bcr-2016-215413","DOI":"10.1136\/bcr-2016-215413"},{"key":"10204_CR272","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1600-0447.1996.tb10635.x","volume":"93","author":"AE Kostako\u011flu","year":"1996","unstructured":"Kostako\u011flu, A. E., Yazici, K. M., Erba\u1e63, T., & G\u00fcvener, N. (1996). Ketoacidosis as a side-effect of clozapine: A case report. Acta Psychiatrica Scandinavica,93, 217\u2013218. https:\/\/doi.org\/10.1111\/j.1600-0447.1996.tb10635.x","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10204_CR273","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1176\/ajp.151.10.1520b","volume":"151","author":"MS Koval","year":"1994","unstructured":"Koval, M. S., Rames, L. J., & Christie, S. (1994). Diabetic ketoacidosis associated with clozapine treatment. American Journal of Psychiatry,151, 1520\u20131521. https:\/\/doi.org\/10.1176\/ajp.151.10.1520b","journal-title":"American Journal of Psychiatry"},{"key":"10204_CR274","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1176\/appi.psy.44.3.249","volume":"44","author":"JM Lafayette","year":"2003","unstructured":"Lafayette, J. M., Pirl, W. F., & Henderson, D. C. (2003). Low-dose clozapine and diabetic ketoacidosis. Psychosomatics,44, 249\u2013252. https:\/\/doi.org\/10.1176\/appi.psy.44.3.249","journal-title":"Psychosomatics"},{"key":"10204_CR275","first-page":"278","volume":"14","author":"J Muench","year":"2001","unstructured":"Muench, J., & Carey, M. (2001). Diabetes mellitus associated with atypical antipsychotic medications: New case report and review of the literature. Journal of the American Board of Family Practice,14, 278\u2013282.","journal-title":"Journal of the American Board of Family Practice"},{"key":"10204_CR276","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s001340100937","volume":"27","author":"J Nicolai","year":"2001","unstructured":"Nicolai, J., Smith, S. J., & Keunen, R. W. M. (2001). Simultaneous side effects of both clozapine and valproate. Intensive Care Medicine,27, 943\u2013943. https:\/\/doi.org\/10.1007\/s001340100937","journal-title":"Intensive Care Medicine"},{"key":"10204_CR277","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1176\/ajp.153.5.737b","volume":"153","author":"GA Peterson","year":"1996","unstructured":"Peterson, G. A., & Byrd, S. L. (1996). Diabetic ketoacidosis from clozapine and lithium cotreatment. American Journal of Psychiatry,153, 737\u2013738. https:\/\/doi.org\/10.1176\/ajp.153.5.737b","journal-title":"American Journal of Psychiatry"},{"key":"10204_CR278","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1192\/bjp.171.1.90c","volume":"171","author":"M Pierides","year":"1997","unstructured":"Pierides, M. (1997). Clozapine monotherapy and ketoacidosis. British Journal of Psychiatry,171, 90\u201391. https:\/\/doi.org\/10.1192\/bjp.171.1.90c","journal-title":"British Journal of Psychiatry"},{"key":"10204_CR279","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1080\/0004867900027","volume":"33","author":"H Smith","year":"1999","unstructured":"Smith, H., Kenney-Herbert, J., & Knowles, L. (1999). Clozapine-induced diabetic ketoacidosis. Australian & New Zealand Journal of Psychiatry,33, 120\u2013121. https:\/\/doi.org\/10.1080\/0004867900027","journal-title":"Australian & New Zealand Journal of Psychiatry"},{"key":"10204_CR280","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0920-9964(01)00331-0","volume":"59","author":"DR Wilson","year":"2003","unstructured":"Wilson, D. R., D\u2019Souza, L., Sarkar, N., Newton, M., & Hammond, C. (2003). New-onset diabetes and ketoacidosis with atypical antipsychotics. Schizophrenia Research,59, 1\u20136. https:\/\/doi.org\/10.1016\/S0920-9964(01)00331-0","journal-title":"Schizophrenia Research"},{"key":"10204_CR281","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1097\/SMJ.0b013e31804b1e4d","volume":"100","author":"KF Marlowe","year":"2007","unstructured":"Marlowe, K. F., Howard, D., & Chung, A. (2007). New onset diabetes with ketoacidosis attributed to quetiapine. Southern Medical Journal,100, 829\u2013831. https:\/\/doi.org\/10.1097\/SMJ.0b013e31804b1e4d","journal-title":"Southern Medical Journal"},{"key":"10204_CR282","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/imj.15986","volume":"53","author":"A Morton","year":"2023","unstructured":"Morton, A. (2023). Diabetic ketoacidosis with severe hypokalaemia and valproate-associated Fanconi syndrome. Internal Medicine Journal,53, 155\u2013156. https:\/\/doi.org\/10.1111\/imj.15986","journal-title":"Internal Medicine Journal"},{"key":"10204_CR283","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1097\/01.SMJ.0000078649.46905.B5","volume":"96","author":"SA Tavakoli","year":"2003","unstructured":"Tavakoli, S. A., & Arguisola, M. S. (2003). Diabetic ketoacidosis in a patient treated with olanzapine, valproic acid, and venlafaxine. Southern Medical Journal,96, 729\u2013730. https:\/\/doi.org\/10.1097\/01.SMJ.0000078649.46905.B5","journal-title":"Southern Medical Journal"},{"key":"10204_CR284","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1001\/archneur.1990.00530100101021","volume":"47","author":"WJ Triggs","year":"1990","unstructured":"Triggs, W. J., Bohan, T. P., Lin, S.-N., & Willmore, L. J. (1990). Valproate-induced coma with ketosis and carnitine insufficiency. Archives of Neurology,47, 1131\u20131133. https:\/\/doi.org\/10.1001\/archneur.1990.00530100101021","journal-title":"Archives of Neurology"},{"key":"10204_CR285","first-page":"257","volume":"52","author":"VD Laghate","year":"2004","unstructured":"Laghate, V. D., & Gupta, S. B. (2004). Acute pancreatitis and diabetic ketoacidosis in non-diabetic person while on treatment with sodium valproate, chlorpromazine and haloperidol. Journal of the Association of Physicians of India,52, 257\u2013258.","journal-title":"Journal of the Association of Physicians of India"},{"key":"10204_CR286","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1345\/aph.1A157","volume":"35","author":"KR Ragucci","year":"2001","unstructured":"Ragucci, K. R., & Wells, B. J. (2001). Olanzapine-induced diabetic ketoacidosis. Annals of Pharmacotherapy,35, 1556\u20131558. https:\/\/doi.org\/10.1345\/aph.1A157","journal-title":"Annals of Pharmacotherapy"},{"key":"10204_CR287","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1042\/CS20160671","volume":"131","author":"M Kerr","year":"2017","unstructured":"Kerr, M., Dodd, M. S., & Heather, L. C. (2017). The \u2018Goldilocks zone\u2019 of fatty acid metabolism; To ensure that the relationship with cardiac function is just right. Clinical Science,131, 2079\u20132094. https:\/\/doi.org\/10.1042\/CS20160671","journal-title":"Clinical Science"},{"key":"10204_CR288","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0140-6736(63)91500-9","volume":"1","author":"PJ Randle","year":"1963","unstructured":"Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963). The Randle cycle (glucose-fatty acid cycle). Lancet,1, 785\u2013789. https:\/\/doi.org\/10.1016\/S0140-6736(63)91500-9","journal-title":"Lancet"},{"key":"10204_CR289","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1006\/bbrc.2001.5608","volume":"287","author":"P Wu","year":"2001","unstructured":"Wu, P., Peters, J. M., & Harris, R. A. (2001). Adaptive increase in pyruvate dehydrogenase kinase 4 during starvation is mediated by peroxisome proliferator-activated receptor \u03b1. Biochemical and Biophysical Research Communications,287, 391\u2013396. https:\/\/doi.org\/10.1006\/bbrc.2001.5608","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10204_CR290","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0003-9861(78)90068-1","volume":"191","author":"RG Hansford","year":"1978","unstructured":"Hansford, R. G., & Cohen, L. (1978). Relative importance of pyruvate dehydrogenase interconversion and feed-back inhibition in the effect of fatty acids on pyruvate oxidation by rat heart mitochondria. Archives of Biochemistry and Biophysics,191, 65\u201381. https:\/\/doi.org\/10.1016\/0003-9861(78)90068-1","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10204_CR291","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/200169a0","volume":"200","author":"PB Garland","year":"1963","unstructured":"Garland, P. B., Randle, P. J., & Newsholme, E. A. (1963). Citrate as an intermediary in the inhibition of phosphofructokinase in rat heart muscle by fatty acids, ketone bodies, pyruvate, diabetes and starvation. Nature,200, 169\u2013170. https:\/\/doi.org\/10.1038\/200169a0","journal-title":"Nature"},{"key":"10204_CR292","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1432-1033.1980.tb04811.x","volume":"109","author":"Y Olowe","year":"1980","unstructured":"Olowe, Y., & Schulz, H. (1980). Regulation of thiolases from pig heart. European Journal of Biochemistry,109, 425\u2013429. https:\/\/doi.org\/10.1111\/j.1432-1033.1980.tb04811.x","journal-title":"European Journal of Biochemistry"},{"key":"10204_CR293","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/0014-5793(84)81201-6","volume":"176","author":"DJ Paulson","year":"1984","unstructured":"Paulson, D. J., Ward, K. M., & Shug, A. L. (1984). Malonyl CoA inhibition of carnitine palmityltransferase in rat heart mitochondria. FEBS Letters,176, 381\u2013384. https:\/\/doi.org\/10.1016\/0014-5793(84)81201-6","journal-title":"FEBS Letters"},{"key":"10204_CR294","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1152\/physrev.1980.60.1.143","volume":"60","author":"AM Robinson","year":"1980","unstructured":"Robinson, A. M., & Williamson, D. H. (1980). Physiological roles of ketone bodies as substrates and signals in mammalian tissues. Physiological Reviews,60, 143\u2013187. https:\/\/doi.org\/10.1152\/physrev.1980.60.1.143","journal-title":"Physiological Reviews"},{"key":"10204_CR295","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.0954-6820.1974.tb08090.x","volume":"195","author":"KE Wildenhoff","year":"1974","unstructured":"Wildenhoff, K. E., Johansen, J. P., Karstoft, H., Yde, H., & S\u00f8rensen, N. S. (1974). Diurnal variations in the concentrations of blood acetoacetate and 3-hydroxybutyrate. Acta Medica Scandinavica,195, 25\u201328. https:\/\/doi.org\/10.1111\/j.0954-6820.1974.tb08090.x","journal-title":"Acta Medica Scandinavica"},{"key":"10204_CR296","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1113\/jphysiol.1980.sp013190","volume":"301","author":"JH Koeslag","year":"1980","unstructured":"Koeslag, J. H., Noakes, T. D., & Sloan, A. W. (1980). Post-exercise ketosis. The Journal of Physiology,301, 79\u201390. https:\/\/doi.org\/10.1113\/jphysiol.1980.sp013190","journal-title":"The Journal of Physiology"},{"key":"10204_CR297","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1172\/JCI105650","volume":"46","author":"OE Owen","year":"1967","unstructured":"Owen, O. E., Morgan, A. P., Kemp, H. G., Sullivan, J. M., Herrera, M. G., & Cahill, G. F., Jr. (1967). Brain metabolism during fasting. Journal of Clinical Investigation,46, 1589\u20131595. https:\/\/doi.org\/10.1172\/JCI105650","journal-title":"Journal of Clinical Investigation"},{"key":"10204_CR298","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1172\/JCI106016","volume":"48","author":"OE Owen","year":"1969","unstructured":"Owen, O. E., Felig, P., Morgan, A. P., Wahren, J., & Cahill, G. F., Jr. (1969). Liver and kidney metabolism during prolonged starvation. Journal of Clinical Investigation,48, 574\u2013583. https:\/\/doi.org\/10.1172\/JCI106016","journal-title":"Journal of Clinical Investigation"},{"key":"10204_CR299","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1093\/cvr\/cvz045","volume":"115","author":"KL Ho","year":"2019","unstructured":"Ho, K. L., Zhang, L., Wagg, C., Al Batran, R., Gopal, K., Levasseur, J., Leone, T., Dyck, J. R. B., Ussher, J. R., Muoio, D. M., Kelly, D. P., & Lopaschuk, G. D. (2019). Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency. Cardiovascular Research,115, 1606\u20131616. https:\/\/doi.org\/10.1093\/cvr\/cvz045","journal-title":"Cardiovascular Research"},{"key":"10204_CR300","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s44161-023-00259-1","volume":"2","author":"GD Lopaschuk","year":"2023","unstructured":"Lopaschuk, G. D., & Dyck, J. R. B. (2023). Ketones and the cardiovascular system. Nature Cardiovascular Research,2, 425\u2013437. https:\/\/doi.org\/10.1038\/s44161-023-00259-1","journal-title":"Nature Cardiovascular Research"},{"key":"10204_CR301","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1203\/00006450-199710000-00013","volume":"42","author":"T Fukao","year":"1997","unstructured":"Fukao, T., Song, X.-Q., Mitchell, G. A., Yamaguchi, S., Sukegawa, K., Or, T., & Kondo, N. (1997). Enzymes of ketone body utilization in human tissues: Protein and messenger RNA levels of succinyl-coenzyme A (CoA):3-ketoacid CoA transferase and mitochondrial and cytosolic acetoacetyl-CoA thiolases. Pediatric Research,42, 498\u2013502. https:\/\/doi.org\/10.1203\/00006450-199710000-00013","journal-title":"Pediatric Research"},{"key":"10204_CR302","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.ejpn.2016.04.003","volume":"20","author":"M Spilioti","year":"2016","unstructured":"Spilioti, M., Pavlou, E., Gogou, M., Katsanika, I., Papadopoulou-Alataki, E., Grafakou, O., Gkampeta, A., Dinopoulos, A., & Evangeliou, A. (2016). Valproate effect on ketosis in children under ketogenic diet. European Journal of Paediatric Neurology,20, 555\u2013559. https:\/\/doi.org\/10.1016\/j.ejpn.2016.04.003","journal-title":"European Journal of Paediatric Neurology"},{"key":"10204_CR303","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/epi4.13138","volume":"10","author":"S Tarrant","year":"2025","unstructured":"Tarrant, S., Liubauske, A., Zhu, G., Zhang, B., Pfeifer, H., Paris, A., Bergin, A. M., & Pinto, A. L. (2025). Exploring the effect of valproic acid levels on patients with epilepsy treated with ketogenic diet: An observational study. Epilepsia Open,10, 615\u2013619. https:\/\/doi.org\/10.1002\/epi4.13138","journal-title":"Epilepsia Open"},{"key":"10204_CR304","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/0006-2952(88)90589-8","volume":"37","author":"T Takeuchi","year":"1988","unstructured":"Takeuchi, T., Sugimoto, T., Nishida, N., & Kobayashi, Y. (1988). Protective effect of D,L-carnitine on valproate-induced hyperammonemia and hypoketonemia in primary cultured rat hepatocytes. Biochemical Pharmacology,37, 2255\u20132258. https:\/\/doi.org\/10.1016\/0006-2952(88)90589-8","journal-title":"Biochemical Pharmacology"},{"key":"10204_CR305","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/S0026-895X(25)10413-6","volume":"30","author":"MJ Olson","year":"1986","unstructured":"Olson, M. J., Handler, J. A., & Thurman, R. G. (1986). Mechanism of zone-specific hepatic steatosis caused by valproate: Inhibition of ketogenesis in periportal regions of the liver lobule. Molecular Pharmacology,30, 520\u2013525. https:\/\/doi.org\/10.1016\/S0026-895X(25)10413-6","journal-title":"Molecular Pharmacology"},{"key":"10204_CR306","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1212\/WNL.31.9.1063","volume":"31","author":"JH Thurston","year":"1981","unstructured":"Thurston, J. H., Hauhart, R. E., Schulz, D. W., Naccarato, E. F., Dodson, W. E., & Carroll, J. E. (1981). Chronic valproate administration produces hepatic dysfunction and may delay brain maturation in infant mice. Neurology,31, 1063\u20131069. https:\/\/doi.org\/10.1212\/WNL.31.9.1063","journal-title":"Neurology"},{"key":"10204_CR307","doi-asserted-by":"publisher","unstructured":"Chandel, N.S. (2021). Amino acid metabolism. Cold Spring Harbor Perspectives in Biology 13: Article a040584. https:\/\/doi.org\/10.1101\/cshperspect.a040584","DOI":"10.1101\/cshperspect.a040584"},{"key":"10204_CR308","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/35043073","volume":"1","author":"H Kornberg","year":"2000","unstructured":"Kornberg, H. (2000). Krebs and his trinity of cycles. Nature Reviews Molecular Cell Biology,1, 225\u2013228. https:\/\/doi.org\/10.1038\/35043073","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"10204_CR309","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/s10038-019-0614-4","volume":"64","author":"S Matsumoto","year":"2019","unstructured":"Matsumoto, S., H\u00e4berle, J., Kido, J., Mitsubuchi, H., Endo, F., & Nakamura, K. (2019). Urea cycle disorders \u2014 Update. Journal of Human Genetics,64, 833\u2013847. https:\/\/doi.org\/10.1038\/s10038-019-0614-4","journal-title":"Journal of Human Genetics"},{"key":"10204_CR310","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1042\/bj2020067","volume":"202","author":"KJ Peuhkurinen","year":"1982","unstructured":"Peuhkurinen, K. J., & Hassinen, I. E. (1982). Pyruvate carboxylation as an anaplerotic mechanism in the isolated perfused rat heart. Biochemical Journal,202, 67\u201376. https:\/\/doi.org\/10.1042\/bj2020067","journal-title":"Biochemical Journal"},{"key":"10204_CR311","doi-asserted-by":"publisher","DOI":"10.3389\/jpps.2024.13040","volume":"27","author":"AM Abdualkader","year":"2024","unstructured":"Abdualkader, A. M., Karwi, Q. G., Lopaschuk, G. D., & Al Batran, R. (2024). The role of branched-chain amino acids and their downstream metabolites in mediating insulin resistance. Journal of Pharmacy & Pharmaceutical Sciences,27, Article 13040. https:\/\/doi.org\/10.3389\/jpps.2024.13040","journal-title":"Journal of Pharmacy & Pharmaceutical Sciences"},{"key":"10204_CR312","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1172\/JCI115030","volume":"87","author":"LH Young","year":"1991","unstructured":"Young, L. H., McNulty, P. H., Morgan, C., Deckelbaum, L. I., Zaret, B. L., & Barrett, E. J. (1991). Myocardial protein turnover in patients with coronary artery disease. Effect of branched chain amino acid infusion. The Journal of Clinical Investigation,87, 554\u2013560. https:\/\/doi.org\/10.1172\/JCI115030","journal-title":"The Journal of Clinical Investigation"},{"key":"10204_CR313","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0026-0495(73)90269-2","volume":"22","author":"P Felig","year":"1973","unstructured":"Felig, P. (1973). The glucose-alanine cycle. Metabolism,22, 179\u2013207. https:\/\/doi.org\/10.1016\/0026-0495(73)90269-2","journal-title":"Metabolism"},{"key":"10204_CR314","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/0967772019866954","volume":"29","author":"RP Rubin","year":"2019","unstructured":"Rubin, R. P. (2019). Carl and Gerty Cori: A collaboration that changed the face of biochemistry. Journal of Medical Biography,29, 143\u2013148. https:\/\/doi.org\/10.1177\/0967772019866954","journal-title":"Journal of Medical Biography"},{"key":"10204_CR315","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1212\/WNL.34.11.1487","volume":"34","author":"JM Warter","year":"1984","unstructured":"Warter, J. M., Marescaux, C., Chabrier, G., Rumbach, L., Micheletti, G., Reitzer, B., Hirsch, E., & Imler, M. (1984). Increase of valproate\u2010induced hyperammonemia in normal subjects by carbohydrate intake. Neurology,34, 1487\u20131487. https:\/\/doi.org\/10.1212\/WNL.34.11.1487","journal-title":"Neurology"},{"key":"10204_CR316","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0022-3565(25)38332-1","volume":"266","author":"M Elhamri","year":"1993","unstructured":"Elhamri, M., Ferrier, B., Martin, M., & Baverel, G. (1993). Effect of valproate, sodium 2-propyl-4-pentenoate and sodium 2-propyl-2-pentenoate on renal substrate uptake and ammoniagenesis in the rat. Journal of Pharmacology and Experimental Therapeutics,266, 89\u201396.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-026-10204-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-026-10204-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-026-10204-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:03:34Z","timestamp":1792141414000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-026-10204-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":316,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10204"],"URL":"https:\/\/doi.org\/10.1007\/s12012-026-10204-w","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"9 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"132"}}